Section Eleven (special): Psychedelics (see chapters 36-38 in section eleven)

Chapter 2001: The Doors of Perception — Psychedelics, the Sacred, and the Healing of a Wounded America
Chapter 2002: The Integration — From the Opened Door to the Inhabited Life
Chapter 2027: The Doors of Perception — Psychedelics, the Sacred, and the Healing of a Wounded America
Chapter 2001: The Doors Within — Psychedelics, Consciousness, and the Long Road Home
Chapter 2026: The Doors of Perception — Psychedelics, the Sacred, and the Healing of a Wounded America
Chapter 1000: Nature Communications
Chapter 800: Ayahuasca, Mushrooms, LSD: Businessman’s Spirituality?
Chapter 700: Psychedelic Assisted Recovery From Trauma And Alcoholism
Chapter 600: The Healing Potential of Psilocybin Cubensis
Chapter 500: Navigating an Unassisted Psychedelic Journey for Health and Wellness
Chapter 21 – Recovery, Healing, and Psychedelics
Chapter 48: A Connection to the Infinite? – Psychedelics and Self-Discovery
Chapter 400: Psychedelics and the Human Mind: A Pathway to Healing and Insight
Chapter 2000: Timothy Leary and Moody Blues

Chapter 2001: The Doors of Perception — Psychedelics, the Sacred, and the Healing of a Wounded America

There is a particular kind of silence that descends after a profound experience. Not the silence of emptiness, but the silence of saturation — a mind so full of what it has witnessed that ordinary language temporarily fails. Those who have traveled deep into a psychedelic experience know this silence intimately. They return from it changed in ways that resist easy description, carrying fragments of understanding that feel simultaneously ancient and radically new.

And yet, beneath that saturated silence, something older still waits. A silence that does not arrive after experience — but that has always existed beneath the noise of ordinary life. Most of us never find it. We are too busy, too anxious, too thoroughly convinced that the next acquisition, the next achievement, the next distraction will finally deliver us to the peace we have always suspected existed somewhere just beyond our grasp.

The psychedelic experience is not a modern invention, despite how aggressively modern culture has tried to either pathologize or commercialize it. Human beings have been deliberately altering their consciousness through plant medicine for tens of thousands of years. The Mazatec shamans of Oaxaca have worked with psilocybin mushrooms since long before recorded history. The indigenous peoples of the Amazon basin have brewed ayahuasca — a potent combination of Banisteriopsis caapi vine and DMT-containing plants — for ceremonial, healing, and spiritual purposes stretching back millennia. The ancient Greeks conducted the Eleusinian Mysteries, a sacred initiation ritual believed by many scholars to have involved a psychedelic brew called kykeon. For most of human history, the deliberate dissolution of ordinary consciousness was not a fringe activity. It was often the most sacred act a culture could engage in.

Then came industrialization, and with it, a peculiar narrowing of acceptable human experience.

This chapter is an attempt to hold several threads together at once: the personal, the historical, the scientific, and the spiritual. It does not pretend to offer final conclusions. The psychedelic experience, almost by definition, resists finality. What it offers instead is a more honest reckoning with what these substances are, what they have meant across time and cultures, what science is now confirming about their mechanisms, and why — at this particular moment in American history — so many people are turning toward them not as an escape from life, but as a doorway back into it.

What Psychedelics Actually Are — And What They Do

To understand why psychedelics matter, it helps to understand what they actually do to the brain — not in the reductive, fear-colored language of the drug war, but with the precision and openness that serious science now brings to the question.

Psychedelics — substances like LSD (lysergic acid diethylamide), psilocybin, ayahuasca, and mescaline — achieve their effects primarily by binding to serotonin receptors in the brain. Serotonin is a neurotransmitter involved in mood regulation, sensory processing, and a host of other biological functions. When a psychedelic molecule occupies these receptor sites, it initiates a cascade of neurochemical events that fundamentally alters the way different brain regions communicate with one another.

The word “psychedelic” itself — coined by psychiatrist Humphry Osmond in 1957, from the Greek for “mind-manifesting” — points toward something that older traditions had always understood. These are not merely drugs in the pharmacological sense. They are instruments of revelation. They manifest what the mind already contains but cannot ordinarily access through the narrow aperture of everyday consciousness.

The ordinary brain operates in highly efficient but deeply habitual patterns. The default mode network — a constellation of brain regions that activates during self-reflection, rumination, and mind-wandering — tends to act as the enforcer of these patterns. It is, in a sense, the neurological address of the ego: the system that generates and maintains our ongoing narrative about who we are, what we deserve, what threatens us, and what is possible. In depression, trauma, and addiction, this network often becomes pathologically overactive — running the same loops of negative self-assessment, shame, and fear on constant repeat, like a broken record that cannot be lifted.

Psychedelics interrupt the default mode network with extraordinary force. Brain imaging studies show that psilocybin, LSD, and ayahuasca all dramatically reduce the activity and internal coherence of this network. As it quiets, something else emerges: a broader, more integrated pattern of connectivity across brain regions that do not normally communicate with each other. The walls between perceptual, emotional, and cognitive systems dissolve. The result is what researchers call increased brain entropy — a state in which the brain is operating with greater flexibility, creativity, and openness to new information.

Research led by Lingyu Zhang at the Beijing University of Posts and Telecommunications revealed that LSD dramatically shifts the balance between excitatory and inhibitory neurons, suppressing the brain’s sensory anchors while liberating its capacity for abstract thought. The biological brakes come off in precisely the regions that generate meaning, insight, and perspective — allowing the mind to make connections it could not have made while constrained within its habitual architecture. A team led by Paolo La-Torraca-Vittori at the University of Pavia found that LSD caused dramatic drops in local brain synchronization — particularly in areas responsible for processing vision and touch. Rather than operating in isolated, hierarchical clusters, the drug flattened the neural architecture, allowing the brain to broadly integrate sensory experience.

This is not incidental. It is, in many ways, the point.

The Entropic Brain: A New Framework for an Ancient Practice

One of the most illuminating frameworks for understanding what psychedelics actually do to the brain is the entropic brain hypothesis, articulated by neuroscientist Robin Carhart-Harris and his colleagues at Imperial College London. In physics, entropy refers to a measure of disorder or randomness. In neuroscience, Carhart-Harris proposed that higher brain entropy corresponds to a more flexible, less predictable, more creative state of neural activity.

Our ordinary minds tend to run on deeply grooved patterns — habitual ways of thinking, rigid emotional responses, fixed narratives about who we are and what our lives mean. These patterns are efficient. But they can also become prisons. By increasing brain entropy, psychedelics dissolve these entrenched neural pathways, offering a temporary window of flexibility during which healthier patterns can be built in their place.

A landmark study published in Nature Communications demonstrated that a single 25mg dose of psilocybin produced measurable physical changes in the brain — denser neural tracts with greater structural integrity — that persisted for a full month after the experience. The brain, in other words, did not merely temporarily alter its function. It rebuilt itself. Participants showed improved performance on cognitive flexibility tests, elevated scores on measures of psychological wellbeing, and greater capacity for adaptive thinking. Those who experienced the greatest surge in brain entropy during their trip showed the most pronounced improvements. The intensity of the journey correlated directly with the depth of the healing.

“Psilocybin seems to loosen up stereotyped patterns of brain activity and give people the ability to revise entrenched patterns of thought,” said Taylor Lyons, a research associate at Imperial College London and lead author of the paper. His senior colleague Robin Carhart-Harris added: “We already knew psilocybin could be helpful for treating mental illness. But now we have a much better understanding of how.”

The mechanism continues to reveal itself at finer and finer resolution. Work led by James Glazer at Northwestern University found that even very low, sub-hallucinogenic doses of LSD — doses carefully calibrated to alter brain function without producing visual hallucinations — restored normal reward processing in individuals with mild depression. Depression characteristically flattens the brain’s response to positive outcomes, making winning, receiving, and succeeding feel hollow. The low dose of LSD temporarily reversed this flattening, generating robust emotional responses to feedback — a sign that the brain was re-engaging with reality with its full motivational range. Participants who showed the strongest neural response also reported the highest improvements in mood, and these improvements lingered for two days after the laboratory session.

A pilot microdosing study conducted at the University of Auckland by Dimitri Daldegan-Bueno and his colleagues enrolled 19 adults with major depressive disorder. Participants microdosed LSD twice weekly for eight weeks, using a smartphone application to track their sleep, mood, and daily functioning. On dosing days, they reported elevated energy, creativity, and social connection. On the two days following each dose, they felt happier and less irritable. Crucially, they reported no tolerance over the eight weeks — no need to increase the dose to maintain the effect, which sets psychedelics apart from nearly every other pharmacological intervention in psychiatry. At the end of the trial, a formal clinical interview revealed an average reduction in depression severity of sixty percent across the group.

“When we saw that certain behavioral characteristics of seizures actually improved in these mice, we were shocked to say the least,” said study author Brenden Rabinovitch.

The entropic, chaotic patterns of electrical activity generated by the drug appeared to make it neurologically impossible for the rigid, hypersynchronized electrical cascades of a severe seizure to organize and propagate. This opens a genuinely new frontier. If psychedelics can protect the brain from the most violent electrical events it experiences, what else might they be protecting us from? What other kinds of pathological rigidity — cognitive, emotional, social — might their controlled application help to dissolve?

When the ego hardens around trauma, around chronic shame, around the accumulated wounds of a difficult life, it stops being a useful organizing principle and becomes a cage. Much of what presents as depression, anxiety, addiction, and existential despair is, at its core, a crisis of the rigid ego. The sufferer is trapped inside a story — about their own worthlessness, their inevitable failure, their fundamental separateness from love and meaning — that feels as immovable as concrete. Conventional talk therapy can illuminate these stories. It can name them, contextualize them, trace them back to their origins. But naming a cage is not the same as opening it.

Psychedelics, under the right conditions, open the cage.

Ayahuasca — the brew of the Amazon prepared from the Banisteriopsis caapi vine and the Psychotria viridis leaf — has been described by those who have worked with it as “ten years of therapy in one night.” That description sounds like hyperbole until you understand what it means experientially: the dissolution of the rigid structures through which you ordinarily perceive yourself, followed by a direct encounter with the deeper, more fluid reality of your own psyche. People emerge from ceremonies describing forgiveness — of themselves and others — that years of conscious effort had failed to produce. They report a reconnection with the natural world, a renewed sense of kinship with other beings, a loosening of the grip of old grief.

As psychologist Rachel Allyn has written, ayahuasca works by dialing down the default mode network — the neurological home of the ego — and in doing so, it can free people from the dysfunctional aspects of ego-consciousness that hold them locked in self-defeating patterns. This is not magic. It is neurochemistry meeting consciousness in a moment of extraordinary permeability.

The dissolution of the default mode network correlates with what the mystics of every tradition have called ego death — the temporary cessation of the ordinary sense of being a separate, bounded self. When this happens, the question of what remains is the oldest question in philosophy. Hindu tradition calls it Atman — the universal self, identical with the ground of all being. Buddhist tradition calls it sunyata — emptiness, the recognition that the self was always a construction rather than a fundamental reality. Christian mysticism, in its more contemplative streams, describes it as union with God — a direct experiential encounter with the divine that transcends all doctrinal formulation.

William James, the great American psychologist and philosopher, argued in his 1902 classic The Varieties of Religious Experience that mystical states — regardless of how they are induced — share four defining characteristics: noetic quality (the sense of having gained genuine knowledge), ineffability (resistance to adequate verbal description), transience (they do not last), and passivity (the sense of being seized by something larger than oneself). The psychedelic experience reliably produces all four. This does not prove that psychedelic mystical experiences are genuine encounters with a transcendent reality. But it does suggest that dismissing them as mere chemical noise is philosophically naive.

The Personal Beginning: What the Body Knows Before the Mind Accepts

My first encounter with LSD occurred when I was a sophomore in high school. I had no grand intentions. A small piece of a saturated pill, scraped with a razor blade to minimize the risk. I took a bus to the downtown library and waited, holding the ordinary world in my hands like a book I’d already read too many times.

What arrived an hour later was nothing short of an internal revolution. A wave of euphoria so clean and so complete that it felt less like a chemical event and more like a homecoming. Peace arrived. Love for strangers arrived. The library’s quiet hum took on a texture and warmth I had never noticed. At fifteen, having never experienced anything of this quality before, I made the mistake of believing I had found the promised land. I had not. But I had found a door — and the knowledge that such a door existed would shape every serious inquiry I would pursue for the rest of my life.

The world did not become strange in those first hours. It became, for the first time, recognizable. There was a warmth in it. A sense of being continuous with the people around me rather than furtively separate from them. The ordinary world — its hallways, its strangers, its banal afternoon light — revealed an interior dimension it had always possessed but had never shown me.

DMT came next, introduced to me by a man at a concert in Washington Park who called it “the businessman’s LSD” — a wry reference to its compressed duration. Where LSD stretched twelve hours across the membrane of consciousness, DMT folded the entire journey into two or three. Its effects were unlike anything I had encountered. Every stranger I met in those two hours felt intimately known to me. Not just friendly — known. I could sense something in them that transcended their surface personality, some deeper harmonic of goodwill and vulnerability that the ordinary social contract usually obscures. The fear of strangers, which had woven itself quietly through my young life, dissolved entirely. What replaced it was a sense of radical kinship — an experience that, I would later discover, is described in nearly identical terms by people who have taken the substance across every culture and demographic in which it has been studied.

A more sober, lasting version of that experience came to me naturally fifteen years later, after genuine recovery from addiction and alcoholism. But the DMT had shown me the territory first — had demonstrated, with chemical certainty, that such a way of being was possible.

Later, during a senior year LSD experience shared with two friends, something stranger occurred. Marc and I began seeing the same hallucinations simultaneously — precisely the same images, arising and shifting in synchrony. When Mike, our host, appeared to both of us as a grinning devil — red horns, crimson face, serpentine tail — we collapsed in laughter that lasted ten minutes. Mike could not see what we saw. This simultaneous shared vision suggested something about the psychedelic state that the pharmaceutical model of consciousness struggles to accommodate: that these substances may, under the right conditions, facilitate a kind of interpersonal permeability that transcends the usual boundaries of individual subjective experience.

My most intense early experience came from a variety of LSD called Orange Sunshine. Under its influence, the world became a living kaleidoscope — walls melting into streams of color, sounds braiding themselves into visual patterns, my entire psychological conditioning lifting away like smoke. What remained when the personality structure dissolved was not terror. It was witnessing. A pure, undifferentiated awareness observing the play of phenomena without the usual layer of identity filtering everything through its preferences and wounds. And in that state, something became luminously clear: that I had vastly more power over how I experienced reality — and other people — than I had ever been permitted to believe. The drug revealed not just an altered state but an expanded one. A glimpse of what the unconditioned human mind might actually be capable of when its crystallized structures momentarily fall away.

I set aside psychedelics in 1980, after a particularly demanding final experience that required two full days before I could recognize myself again. For one of those days, I was genuinely uncertain the journey back was possible. The drugs had shown me everything they could show me at that stage of my development. The rest of the work, I understood, would have to come through other disciplines — through meditation, mindfulness, recovery, and sustained spiritual practice. And for more than four decades, that is precisely how I proceeded.

But the door, it turned out, was not permanently closed. In October of 2022, I participated in a 14-hour spiritual retreat that proved to be the most powerful and transcendent experience I had undergone in many years — one I will describe in full in the following chapter. It reminded me, with the force of direct experience, that the plant medicines do not exhaust their offerings after a single season of one’s life. They wait, with the patient intelligence of the natural world, for the moment of genuine readiness. That readiness, it seems, can arrive again, even after decades have passed.

I carry no regret for any of the journeys taken — in youth, or in the later renewal of 2022. They were real. They showed me things that nothing else had shown me. And though I have found my way to similar territories through meditation, mindfulness, and sustained spiritual practice, I recognize that for many people — perhaps most — such natural pathways are inaccessible without some initial loosening of the grip.

The Long Tradition: Psychedelics Through the Ages

To treat psychedelics as a 1960s phenomenon is to misunderstand them at the most fundamental level. Human beings have always reached for altered states of consciousness. The question is not whether this reaching is natural — it clearly is — but whether the reaching is purposeful, prepared, and integrated into a larger framework of meaning.

The use of plant medicines for healing and spiritual insight is among the oldest documented human practices on earth. Ayahuasca ceremonies have been conducted in the Amazon for at least a thousand years, and likely far longer — the brew itself seems designed by nature as a pharmacological marvel, combining a monoamine oxidase inhibitor from the vine with DMT from the leaf to create an orally active psychedelic that would not otherwise function through ingestion. Peyote has been used ceremonially by indigenous peoples of North America for thousands of years. Psilocybin mushrooms appear in Mesoamerican murals and sacred art dating back centuries.

Anthropologist Terence McKenna, who spent decades studying the relationship between psychedelics and human consciousness, argued provocatively that the consumption of psilocybin mushrooms by early hominids may have been a driving force in the rapid expansion of human cognitive capacity. Whether or not one accepts this specific hypothesis, it points toward something important: the encounter between human neurology and psychoactive plants is far older than civilization itself. It predates writing, formal religion, and organized government. In some meaningful sense, it may have helped to produce them.

The Eleusinian Mysteries, conducted annually for nearly two thousand years in ancient Greece, initiated participants — including Plato, Aristotle, and Cicero — into experiences they described as the most significant of their lives. Initiates took a solemn oath never to fully describe what they witnessed, and largely kept it. What they did report was a complete dissolution of the fear of death, a direct encounter with what Greek culture called the divine, and a transformation of how they understood the relationship between individual life and the cosmic whole. The classicist Carl Ruck and mycologist R. Gordon Wasson have made compelling arguments that the kykeon — the ceremonial drink consumed at Eleusis — contained ergot, a fungus that grows on grain and produces compounds chemically related to LSD.

In Mesoamerica, the Aztecs called psilocybin mushrooms teonanácatl — “flesh of the gods.” The Mazatec curandera María Sabina, who in 1955 permitted the first Westerner to participate in a mushroom ceremony, described the mushrooms themselves as speaking through her during healing rituals. They were not consumed recreationally. They were consulted. The distinction matters enormously.

In the Amazon, ayahuasca is understood by the indigenous communities that use it not merely as a plant medicine but as a teacher — an intelligence that exists within the natural world and communicates through the altered state. Sessions are conducted by trained healers called curanderos or ayahuasceros, who spend years learning how to hold the space for participants and navigate the terrifying and beautiful terrain the medicine opens. The integration of the experience into daily life is considered as important as the experience itself.

This context — of ritual, preparation, trained guidance, and integration — is what distinguished traditional psychedelic use from the chaotic recreational experimentation of the twentieth century. When Timothy Leary urged millions of young Americans to “turn on, tune in, drop out” with little guidance, little preparation, and no cultural container capable of holding what was released, the results were predictably mixed. Some people had genuinely transformative experiences. Others were psychologically undone by them. The tragedy was not the substances themselves, but the absence of the wisdom traditions that had always accompanied their use.

Nature, understood in this light, is not merely a backdrop to human existence but an active healing intelligence. Plant medicines are her offering. As Deepak Chopra, Gabor Maté, and many other prominent healers have argued, the therapeutic potential of psychedelics is not a modern discovery — it is a modern rediscovery of something our ancestors knew and our culture systematically suppressed in its anxious drive toward rational control.

The Healing of Meaning: What Depression Actually Is

The data on psychedelics is important. But data alone does not capture what is at stake in this conversation — particularly for Americans navigating an existence that offers unprecedented material comfort alongside epidemic-level rates of loneliness, purposelessness, and despair.

Depression, in its deeper nature, is not merely a chemical imbalance. It is a crisis of meaning. It is the experience of being trapped — inside a body, inside a story, inside a self — with no apparent exit and no evident reason to endure the confinement. It is the ossification of possibility, the conviction that the future will be only a repetition of the past. The rigid ego is the vehicle of this entrapment. It maintains the prison through the relentless recycling of familiar thought-forms: I am not enough. I am fundamentally alone. The world is indifferent. Nothing will change.

These are not beliefs that yield readily to argument. They have been installed in the deepest layers of the psyche, often through early trauma, sustained neglect, or the simple relentless pressure of a culture that measures human worth in terms of productivity and consumption. Talking about them is helpful. Understanding their origins is valuable. But the locked door of depressive consciousness often requires something more radical than verbal access.

What psychedelics can provide — not always, not automatically, not without careful preparation and integration — is a direct experience of the mind’s own vastness. The depressive prison is real, but it is not the whole of consciousness. Beneath and around and through it, something else exists: a field of awareness that is not defined by the ego’s suffering, not bounded by its stories, not imprisoned by its conclusions. Contact with that field — even briefly, even imperfectly — can be enough to shift the entire orientation of a life.

The question is not whether these experiences are real. They are. The question is how to make them safely and responsibly accessible to the people who need them most.

The American Context: Healing in an Age of Emptiness

America has a particular kind of wound. It is not a wound of poverty alone, or violence alone, or inequality alone — though all of these are real and serious. It is the wound of disconnection. A culture organized around consumption and competition produces citizens who are extraordinarily productive and extraordinarily lonely. The rates of depression, anxiety, addiction, and suicide in the United States are not incidental to its social organization. They are expressions of it.

Nearly a third of American adults report symptoms consistent with a diagnosable anxiety or depressive disorder. Overdose deaths continue to mount, each one representing not simply a failed intervention but a life that found no adequate reason to remain. The opioid crisis — which began as a pharmaceutical marketing campaign and metastasized into a national catastrophe — is best understood as a mass attempt to medicate a pain that is not purely biological. It is existential. People are reaching for something. They are trying to feel something, or to stop feeling something, or to find some brief respite from a life that offers sensation without meaning, stimulation without depth, connection without intimacy.

Conventional psychiatry offers partial answers. Antidepressants help many people. Talk therapy helps many people. But the blunting of emotional pain through pharmaceutical management is not the same as the restoration of meaning. A quieter depression is still a depression. And for the growing number of Americans whose conditions resist conventional treatment — estimated at thirty to forty percent of those with major depressive disorder — the current pharmacological toolkit has essentially run out of options.

This is the context in which psychedelic-assisted therapy re-emerges not as a novelty or a controversy but as a genuine medical and cultural necessity. When a population is suffering at this scale from conditions that reflect a fundamental disconnection from self, from others, from nature, and from meaning, the substances that have most reliably produced reconnection across human history deserve serious and urgent attention.

Research on psilocybin for treatment-resistant depression has produced response rates that dwarf those of conventional antidepressants. Studies at Johns Hopkins, NYU, and Imperial College London have demonstrated lasting reductions in depression and anxiety after one or two guided sessions with psilocybin — effects that persist for months and sometimes years. MDMA-assisted psychotherapy for PTSD has shown response rates so strong that the FDA granted it Breakthrough Therapy designation. Ketamine — already legal and in clinical use — is demonstrating rapid anti-suicidal effects that no other intervention can reliably achieve.

But beyond the clinical data, something else is happening. People who undergo psychedelic-assisted therapy do not typically describe it as having their symptoms reduced. They describe it as having recovered something they did not know they had lost — a connection to their own aliveness, a sense of being part of something larger than their personal history, a capacity for wonder that anxiety and depression had gradually strangled. These are not small gains. These are the gains that make a life worth living.

Research by James M. Zech at Florida State University, analyzing federal health data from nearly 140,000 American adults, found that people who had used LSD in the past year were thirty percent less likely to meet diagnostic criteria for alcohol use disorder than non-users. Among those who did have the disorder, recent users reported fifteen percent fewer symptoms. The psychological shifts associated with LSD — increased openness, reduced neuroticism, a wider sense of perspective — appear to chip away at the psychological architecture of addiction from the inside.

The Spiritual Dimension: What Science Cannot Fully Measure

Science is extraordinarily good at describing mechanisms. It can tell us which receptors are bound, which brain networks are suppressed, which electrical patterns emerge. What it is less equipped to address is the content of the psychedelic experience itself — and for millions of people across thousands of years, that content has been primarily spiritual in nature.

Bill Wilson, the co-founder of Alcoholics Anonymous, understood this intuitively. Twenty years into his own recovery from alcoholism, suffering from chronic depression that sobriety alone could not lift, Wilson began experimenting with psychedelic therapy in 1955. He believed — based on direct experience — that the spiritual awakening he had undergone in the 1930s, which had freed him from addiction, could be made available to others through psychedelic-assisted therapy. He was particularly interested in reaching those who, despite their sincere desire for recovery, could not access the felt sense of a higher power through conventional means.

This insight has found its fullest modern expression in the work of researchers at Johns Hopkins University and NYU, who have demonstrated that psilocybin-assisted therapy produces mystical experiences in the majority of participants — and that the intensity of the mystical experience is the single strongest predictor of therapeutic outcome. People who report feeling a profound sense of unity, love, and connection during their session show the greatest long-term reductions in depression, anxiety, and addiction. The spiritual and the therapeutic are not separate dimensions. They appear to be the same thing, approached from different angles.

Deepak Chopra, Gabor Maté, Dick Schwartz — some of the most respected voices in integrative medicine and trauma therapy — have all recognized the therapeutic and spiritual potential of psychedelic-assisted work. Maté, whose work on trauma and addiction has reached millions of readers, has participated in and facilitated ayahuasca ceremonies, and describes them as among the most powerful healing interventions he has encountered in a long career. Schwartz, the developer of Internal Family Systems therapy, has observed that psychedelics appear to create rapid and lasting access to what he calls the Self — the compassionate, curious, centered core of human identity that trauma has buried under layers of defensive reaction.

Indigenous peoples knew all of this. They did not need clinical trials to tell them that plant medicines could dissolve the fear of death, heal the wounded psyche, and restore a sense of connection to something larger than the individual ego. They had been observing these effects, developing protocols for working with them, and transmitting that knowledge through lineages of trained healers for hundreds of generations. The modern psychedelic renaissance does not represent the discovery of something new. It represents the slow, halting return of Western culture to something very old — something that was never lost, only deliberately forgotten.

The Frontier of Non-Hallucinogenic Neuroplasticity

Scientists at the University of California, Davis have taken the neurological inquiry a step further still — engineering a chemical analogue of LSD called JRT, which preserves the drug’s extraordinary capacity to promote neuroplasticity while removing the hallucinogenic component entirely. In laboratory studies, JRT promoted substantial growth in dendritic branches — the neural structures through which brain cells communicate — exceeding even the performance of the original compound. It reversed brain damage induced by chronic stress. It improved cognitive flexibility. And it did all of this without producing the perceptual alterations that make full psychedelic experiences therapeutically risky for certain populations.

“Even small chemical alterations to the structures of psychedelics have the potential to profoundly improve their safety and efficacy profiles,” said lead researcher David Olson.

In live animals, a single dose reversed brain damage induced by chronic stress and increased synapse density in the prefrontal cortex. If these results translate to human clinical settings, they suggest the possibility of treating severe neurological conditions — including schizophrenia, where cortical atrophy is a hallmark feature — with non-hallucinogenic psychedelic derivatives. The molecule may be separable from the mystical experience it ordinarily accompanies — and both may have independent therapeutic value.

This is not reductionism. It is precision. It is the kind of careful, incremental scientific work that takes seriously both the promise and the responsibility of operating at the edge of what the human mind can withstand. The hallucinogenic experience retains its own irreplaceable value — there are healing dimensions of the full journey that chemistry alone cannot replicate. But for those for whom that journey is medically contraindicated, JRT and its successors may offer a different door into the same territory of restoration.

None of this means that psychedelics are safe for everyone, or that they should be consumed carelessly, or that the current legal restrictions on them are simply obstacles to be circumvented. The same properties that make these substances profoundly healing can make them profoundly destabilizing in the wrong context. Those with personal or family histories of psychosis or schizophrenia face genuine risks. People who approach these substances without psychological preparation, without a safe container, without skilled guidance, and without any plan for integration expose themselves to experiences that can be disorienting rather than healing.

The wisdom traditions understood this. They did not hand ayahuasca to strangers at parties. They built elaborate protocols of dietary preparation, psychological readiness, experienced guidance, and communal support. They understood that the journey is only half of the medicine — that what you do with what you see, in the weeks and months after the experience, determines whether the door that was opened leads somewhere or simply leaves you exposed to the elements.

The emerging field of psychedelic-assisted therapy is attempting to rebuild these containers within a modern clinical framework. Therapists who work in this field undergo extensive training. Sessions are carefully prepared, carefully supported, and followed by structured integration work. The results, even within these early protocols, are remarkable. They are also a reminder that the power of these substances is not in the chemistry alone. It is in the chemistry meeting the prepared mind, in the right setting, with the right support, toward a genuine intention.

There are real limitations that must be named honestly. The psychedelic research literature is still young. Many of the most compelling studies involve small sample sizes. The demographics of clinical trial populations tend to be narrow. Open-label designs introduce the possibility of placebo effects, particularly with substances as culturally storied as LSD and psilocybin. And the matter of integration — what happens after the experience — cannot be overstated. A psychedelic journey can dissolve rigid patterns and open new psychological territory. But the work of building durable new habits, relationships, and ways of being in that newly opened territory requires sustained effort, skilled support, and time. The experience is not the cure. It is the opening through which cure becomes possible.

What is needed now is the courage to take this work seriously at scale. The mental health crisis in America is not a peripheral problem — it is a defining feature of contemporary life. Hundreds of millions of people globally live with depression, trauma, and addiction that conventional treatments cannot adequately address. The entrenchment of pharmaceutical and psychiatric orthodoxies has left enormous unmet need. Into that need, psychedelics are arriving — not as a counterculture curiosity, but as rigorously studied agents of genuine change.

The Long Path and the Catalyst That Serves It

There is a temptation, when encountering the research on psychedelics, to reach for them as a solution to the long, difficult work of psychological and spiritual growth. This temptation deserves honest examination.

Psychedelics are not a shortcut. They are a catalyst. They can compress into a single afternoon experiences that might otherwise take years of meditation, therapy, or contemplative practice to access. But the insights they offer still require integration. The door they open still requires you to walk through it, repeatedly, in the ordinary moments of your daily life. The man who sees the unity of all beings during a psilocybin session and returns home to treat his family with contempt has not been healed. He has been shown something he is not yet ready to live.

For more than four decades, my own path led me primarily through meditation, mindfulness, physical health, and genuine human connection as the central vehicles of my continuing development. Not because the substances had nothing left to offer, but because the work they had begun required a different kind of attention to complete. The sacred silence they had introduced me to — that space of pure awareness beneath the chattering personality — could be accessed, more quietly and more durably, through disciplines that required no chemical assistance at all.

And yet, in October of 2022, life returned me to the threshold of that original door. The experience I underwent in that 14-hour retreat — which I recount in full in the following chapter — confirmed what I had come to suspect through decades of contemplative work: that the plant medicines do not belong only to the young and the searching. They remain available to the elder, the long-practitioner, the one who believes he has mapped most of the interior terrain. They find the unmapped rooms. They illuminate, with loving and sometimes devastating precision, precisely the attachments that sustained spiritual practice has not yet dissolved.

Bill Wilson believed that psychedelics could help those who could not access spiritual awakening through conventional means. Deepak Chopra and Gabor Maté believe they can accelerate healing that other interventions cannot reach. The researchers at Johns Hopkins and NYU believe they can address the treatment-resistant depression, terminal anxiety, and entrenched addiction that have resisted every other tool modern psychiatry has developed. Sharon and I have spent years studying these possibilities with genuine open-mindedness, and we remain genuinely open to what they may yet offer us on our own continuing journey toward what I can only call the infinite unfolding.

A Final Word: The Silence Beneath the Noise

What is clear is this: the substances that human beings have been using for thousands of years to dissolve the illusion of separateness, to encounter the sacred, to heal the wounded mind, and to restore the felt sense of meaning to a life that had lost it — these substances are not the enemy. They are, if anything, among the oldest allies the human species has.

The real question is not whether they work. The evidence, historical and scientific, is overwhelming that they do.

The real question is whether we are ready to work with them — honestly, carefully, humbly, and with the full weight of responsibility that accompanies any genuine encounter with the depths of the human mind.

There is a silence that lives beneath the noise of ordinary life. Psychedelics, at their best, provide a temporary passage to that silence — not by adding something foreign to the mind, but by removing the habitual structures that prevent the mind from recognizing its own nature. What is encountered there cannot always be brought back intact. Language fails at the border. But something comes back. A different relationship to one’s own suffering. A memory of spaciousness. A loosened grip on the story that had seemed inescapable.

That is not nothing. For many people, it is everything.

The work of healing — individual and collective — is always a long path. It requires integrity, sustained practice, honest relationships, and the willingness to encounter what we have most carefully avoided. Psychedelics do not replace that work. They do not offer the kind of salvation that can be purchased or swallowed without consequence. But they can open a door that had seemed permanently sealed. And for the soul in genuine crisis — whether at the threshold of adult life or deep in its later reaches — that opening, however brief, however bewildering, can be the beginning of a return to life.

Chapter 2002: The Integration — From the Opened Door to the Inhabited Life

There is a particular kind of morning that arrives after a genuine reckoning with the depths of oneself. It looks, at first glance, entirely ordinary. The light through the window is the same light. The body is the same body, with its familiar aches and habits. The coffee cup sits in the same place on the counter. And yet something has shifted — not in the furniture of the world, but in the one who is perceiving it. The walls of the habitual self have become slightly more permeable. The story that had once seemed immovable now shows its seams.

This is the morning that follows the opening of the door.

The question that every serious practitioner of psychedelic work — and every serious practitioner of any contemplative tradition — must eventually confront is not how to open the door. It is how to live in what the door reveals. Psychedelics, as the previous chapter explored, are among the most powerful catalysts for that initial opening the human species has ever encountered. They dissolve the default mode network’s iron grip on identity, interrupt the rigid loops of depressive and traumatized consciousness, and offer — sometimes with shattering immediacy — a direct encounter with the mind’s own vastness. They show the imprisoned the size of the prison, and then, briefly, remove its walls.

But the prison was built over years, over decades, over a lifetime of accumulated wounding, cultural conditioning, and inherited narrative. It does not stay demolished simply because it was once dissolved. The architecture of habitual consciousness is extraordinarily resilient. Patterns that were loosened during a psilocybin session or an ayahuasca ceremony will, without sustained attention, gradually reassemble themselves — like water finding the grooves it has carved in stone over centuries.

This is not a failure of the medicines. It is, in its own way, a teaching. The catalytic experience is not the destination. It is the beginning of a path that requires an entirely different set of disciplines to walk.

What those disciplines look like — how they are practiced, how they fail, how they gradually transform the ground on which a life is built — is the subject of this chapter. Not as abstract prescription, but as the lived testimony of one who has traveled both the catalytic and the long way, and arrived at a place where the two no longer seem opposed.

What Integration Actually Means

The word “integration” has become something of a technical term in psychedelic-assisted therapy circles — a clinical container for the work that follows the session. Therapists speak of integration windows, integration sessions, integration practices. The word is useful, but it risks reducing something vast and demanding to a manageable-sounding item on a therapeutic checklist.

What integration actually means is closer to this: the willingness to allow what was revealed under the influence of the medicine to change the way you actually live. Not symbolically. Not intellectually. Not in the curated version of yourself you present to others. In the actual choices, relationships, patterns of avoidance, habits of self-regard, and ways of meeting difficulty that constitute the fabric of an ordinary day.

This is, of course, the hardest thing. It is far easier to have a profound experience than to let that experience reorganize you. The ego, as was described in the previous chapter, is extraordinarily resilient. It absorbs insight the way a body absorbs shock — accepting the impact, processing it through existing structures, and reconstituting itself as close to its previous configuration as possible. The man who wept at the unity of all being during his psilocybin session and returned to treating his family as instruments of his own emotional management has not failed because he is dishonest or weak. He has encountered the fundamental human difficulty: that seeing something clearly and living consistently from that clarity are entirely different undertakings.

Eric Hoffer, that unlikely dock worker turned philosopher, observed that many of the insights of the saint stem from their experience as sinners. The knowledge gained in the depths — whether those depths are reached through plant medicine, through catastrophic suffering, or through the long discipline of contemplative practice — does not automatically translate into lived transformation. It becomes material. Raw material for the sustained, often unglamorous, always demanding work of becoming what one has glimpsed oneself capable of being.

This is the work that follows the opened door.

The Examined Life as Daily Practice

Socrates’ famous assertion — that the unexamined life is not worth living — is usually treated as a philosophical declaration. But for those who have sat in ceremony, who have undergone the dissolution of ordinary self-structures and encountered the deeper substrate of their own consciousness, it arrives as something more immediate: a description of the actual stakes.

The unexamined life, in this context, does not simply mean a life lived without intellectual reflection. It means a life in which the stories that run the person — the deep, sub-verbal narratives about worthlessness, about separateness, about the impossibility of real change — are never brought into the light of sustained, honest, compassionate attention. It means a life in which the default mode network’s habitual productions are accepted as reality rather than recognized as constructions. It means, in the most precise sense, a life lived inside the prison without ever questioning the walls.

Mindfulness — the disciplined, sustained practice of attending to present-moment experience without the overlay of habitual judgment — is the primary instrument through which the examined life is actually conducted. Not as a technique for relaxation or stress reduction, though it may offer those as secondary benefits, but as a fundamental epistemological tool: a way of seeing what is actually occurring in one’s own consciousness, moment by moment, with sufficient clarity and stability to begin making different choices.

In my own history, the first serious encounter with mindfulness arrived not in a meditation hall but in the raw, uncomfortable necessity of the Twelve Steps. Taken seriously — which is to say, taken as a genuine invitation to honest self-examination rather than as a behavioral contract — those steps constitute one of the most effective programs of contemplative self-inquiry ever developed outside of a formal religious tradition. The fourth step’s fearless moral inventory is not, at its deepest level, an exercise in cataloguing wrongdoing. It is a practice of seeing — of bringing into conscious awareness the patterns of fear, resentment, self-deception, and defensive reaction that have been running the life largely unexamined.

What the psychedelic experience offered, at its most transformative, was a compressed and dramatically intensified version of exactly this kind of seeing. The difference was one of depth and speed. Where the slow work of the Twelve Steps might reveal, over months, the shape of a particular defensive pattern, a single ceremony could illuminate the entire architecture of that pattern — its origins, its emotional logic, its cost — in a matter of hours. The medicine is not a substitute for the long work. But it can make visible, with great efficiency, precisely what the long work most needs to address.

The 2022 Retreat: A Return to the Threshold

In October of 2022, I participated in a 14-hour spiritual retreat that became the most profound concentrated experience of my later life. The facilitator administered psilocybin in the form of a carefully prepared elixir — combined with five additional varieties of non-hallucinogenic mushrooms and supportive herbs — and then guided me, with great skill and evident wisdom, through what followed.

In the early hours of the experience, I lost all interest in language. The verbal dimension of consciousness — that constant interior monologue through which the self narrates and interprets its own existence — simply quieted. What remained was something I can only describe as witnessing: a pure, undifferentiated awareness attending to the play of both inner and outer phenomena with a quality of presence that the ordinary, loquacious mind perpetually obscures.

When speech returned, some three hours later, the facilitator asked me questions with the precision of a skilled surgeon. One in particular struck with the force of sudden recognition.

She asked me why I did not recognize myself as a beautiful person.

My response, on the surface, was reasonable. I was in my late sixties. The body showed the decades — psoriasis, the marks of skin cancer, the visible signs of time. My relationship to my body image had long since been released, I believed, from the anxious vanity of youth. I had found my life’s partner decades earlier. I had long ago, I thought, moved beyond the body’s surface into territory where such considerations no longer applied.

What the facilitator saw — and what the altered state allowed me to see alongside her — was something more precise and more troubling. The conviction that my worth resided exclusively in my interior life, in the quality of my consciousness and my spiritual development, was not, as I had assumed, the sign of genuine transcendence. It was, in its own subtle way, another form of rejection. Another variety of the ancient wound. I had divided myself — deemed the interior acceptable, even beautiful, while consigning the physical vehicle of that interior to a category of irrelevance that was, upon honest examination, indistinguishable from contempt.

The facilitator put it with disarming directness. If beauty exists only inward, she told me, you are still living entirely from the head. Beauty is of the whole being — body, mind, and spirit — and it is a reflection of connection with the natural world and the universe from which we are not, and have never been, separate. The failure to receive oneself as beautiful in this total sense is not humility. It is a residue of a wound — the wound of having been told, in a thousand explicit and implicit ways, that one’s appearance, one’s presence, one’s very body was not adequate to the standard being applied.

I recognized, in that moment, the through-line of decades. The peer rejections of childhood. The quiet, internalized verdict of inadequacy that had never fully been brought to light, because it had been so effectively buried beneath the compensatory structures of spiritual achievement and intellectual development. I had, in the language of the work, painted over the damaged foundation rather than repairing it. The new paint was genuine — the meditation, the recovery, the years of contemplative practice had produced real transformation. But the rot beneath it had been waiting, patient as any truth, for a moment of sufficient permeability to be seen.

There was another revelation, equally unexpected, that arose in the same session. While in the elevated state — that condition of reduced ego-opacity in which the psyche’s deeper structures become visible without the usual defensive mediation — I could see with perfect clarity that I had been treating my own writing in precisely the same way I had been treating my body. The same auto-immune logic that had been attacking my physical self-image was attacking my written voice. I had been trying to make my writing more presentable, more palatable, more readable by imagined standards of general accessibility — and in doing so, I had been betraying the particular, irreplaceable quality of consciousness that the writing existed to express. The botox applied to the aging face and the editorial smoothing applied to an authentically irregular voice were, at root, the same gesture: the gesture of self-betrayal masquerading as self-improvement.

The body and the writing are, the experience revealed, temporary containers for an infinite spiritual potential. They were never meant to meet an external standard of acceptability. They were meant to serve as channels — imperfect, particular, irreplaceable channels — for the expression of the consciousness they house.

This is what the medicine shows, at its most essential: not a more perfected version of the self one has been presenting to the world, but the self that exists prior to the presenting — the self that was never wounded in its essence, however deeply its structures were marked by what it survived.

The Body of the Work: Practices for a Lived Awakening

The insights of ceremony and of the retreat require, as every serious practitioner has recognized, a container in which they can be metabolized and lived. Without that container, even the most shattering revelation becomes, over time, a memory — vivid, perhaps transformative in its tone, but increasingly remote from the daily choices that constitute an actual life.

The five practices that I have found most essential to that container are not exotic. They are, in many respects, the same practices that every serious contemplative tradition has recommended for millennia. What the psychedelic experience — and the mature retreat experience specifically — contributed was not new knowledge of what the practices were, but a renewed visceral urgency about why they matter.

The Practice of Honest Self-Inventory. The Twelve Steps, reinterpreted not as a program of behavioral compliance but as a framework for genuine self-examination, offer one of the most practical and complete systems for this ongoing work. The fourth step’s fearless inventory — taken not once but continuously, as a living practice of self-honesty — is the secular equivalent of what every contemplative tradition calls conscience examination. It requires naming, with compassion and without evasion, the places where fear, resentment, and self-deception continue to operate. It requires distinguishing, repeatedly and with great patience, between the wounds one has received and the wounds one has inflicted. And it requires, ultimately, the willingness to bring that naming into relationship — to speak honestly with another, as the fifth step prescribes, because the secrets we keep in isolation calcify in ways that honest speech dissolves.

The Practice of Mindful Presence. The default mode network does not sleep. Its productions — the recycled narratives, the self-assessments, the catastrophizing projections — resume almost immediately after any experience of their dissolution. Mindfulness practice, in its most basic form, is the daily practice of noticing this resumption without being captured by it. The instruction to observe thoughts as clouds passing across the sky is not a prescription for detachment. It is a prescription for the kind of presence that sees what is actually occurring — in the body, in the emotional field, in the quality of one’s attention — and thereby creates, however briefly, the space in which a different choice becomes possible.

The Practice of Bodily Honoring. The lesson of the 2022 retreat — that the body is not an obstacle to spiritual development but a sacred instrument of it — demands a practice of its own. For many of us, particularly those who have survived early trauma or who have used substances or spiritual ideology to escape from somatic experience, the body remains the last frontier of genuine self-acceptance. To honor the body is to attend to it — not with the anxious scrutiny of the self-critic, but with the quality of attention one might bring to something sacred. Movement, rest, adequate nourishment, exposure to the natural world — these are not merely health recommendations. They are forms of spiritual practice in which the universal intelligence that animates consciousness expresses itself through the particular vehicle it has been given.

The Practice of Community. Healing does not occur in isolation. This is not a sentiment — it is a neurological fact. Human beings are wired for co-regulation. The nervous system of a person in chronic dysregulation cannot fully regulate itself in the absence of sustained, safe, attuned relationship. The AA meeting, the meditation community, the integration circle, the honest conversation with a trusted friend — these are not auxiliary to the work of transformation. They are the medium in which transformation becomes sustainable. What the psychedelic experience can catalyze individually, community sustains collectively. And what is sustained collectively eventually reshapes culture.

The Practice of Service. The twelfth step of every serious recovery tradition points toward the same recognition: that the transformation of the individual finds its fullest meaning in its extension toward others. Not as obligation, not as performance of virtue, but as the natural expression of a consciousness that has genuinely recognized its own connection to the larger whole. To serve — in whatever form is authentic to one’s particular gifts and circumstances — is to enact, in the dailiness of ordinary life, what the most transcendent psychedelic experience reveals in its most elevated moments: that we are not separate. That the wellbeing of another is not, at the deepest level, distinguishable from our own.

The Convergence: Where the Medicine Meets the Path

Bill Wilson understood something that clinical researchers are only now beginning to be able to articulate with empirical precision: that spiritual awakening and therapeutic healing are not two different things approached from different angles. They are the same thing, described in different languages.

The psilocybin session that produces a mystical experience of unity and love is the same event, viewed simultaneously from a neurological and a phenomenological perspective. The default mode network quiets. The walls between self and world become permeable. The ego’s habitual productions cease to dominate the field of awareness. And what is encountered in that cleared space — whatever name one applies to it, whatever tradition one draws upon to interpret it — is experienced as simultaneously more real and more fundamental than the ego-consciousness that ordinarily mediates one’s existence.

What every serious tradition has called enlightenment — the Greek mysteries called it mystical union, the Buddhists call it awakening, the Christian contemplatives call it union with God, the indigenous traditions call it by many names — is not a destination that psychedelics deliver. It is a territory that they glimpse. The sustained inhabiting of that territory — the genuine transformation of the ordinary life in alignment with what was seen — is the work of decades, of sustained practice, of honest relationship, of the willingness to be changed by what one has encountered.

This is the integration that matters. Not the integration session on the day after the ceremony, though that too has its place. But the integration of the session’s revelations into the actual texture of how one lives — how one treats one’s body, how one speaks to one’s partner, how one meets one’s work, how one encounters the stranger on the street, how one sits with difficulty rather than reaching, reflexively, for its alleviation.

The plant medicines do not exhaust their teaching with a single season of a life. The 2022 retreat confirmed this with the force of direct experience. Decades of meditation, recovery, and contemplative practice had carried me far — further, I had sometimes believed, than I had any right to expect. But the medicine found the unmapped rooms. It illuminated, with the characteristic loving precision that those who have worked with it will recognize, precisely the attachments that sustained practice had not yet dissolved.

That is not a critique of the path already walked. It is an invitation to continue walking.

A Final Word: The Wholeness That Was Always There

Healing is not the addition of something new to a fundamentally broken self. It is the removal of what was added — the layers of conditioning, wounding, and compensatory structure that accumulated over a lifetime of navigating an imperfect world with an incompletely supported nervous system. Beneath those layers, in every human being without exception, there is what the psychedelic experience reliably encounters: a field of awareness that is not defined by its history, not bounded by its wounds, not imprisoned by its inherited conclusions about what is possible.

The medicines open a passage to that field. Mindfulness, practiced with honesty and sustained patience, makes that passage accessible without chemical assistance, in the ordinary moments of an ordinary day. Recovery — genuine recovery, in its fullest spiritual sense — is the long practice of learning to live from that field rather than from the accumulated structures that obscure it.

None of this is easy. The promise of a quick path — five minutes of meditation, a single ceremony, a book that delivers illumination without the demand for genuine change — is seductive precisely because the real work is demanding. But there are no shortcuts through the interior. There are only more or less efficient routes to the same destination: the honest encounter with what one actually is, beneath the story of what one has been.

The silence that the previous chapter described — the silence that lives beneath the noise of ordinary life — is not a silence that psychedelics create. It was always there. It is there in this moment, beneath the reading of these words, beneath the thoughts that arise in response to them, beneath the entire elaborate production of the interpreting, judging, story-making mind.

Psychedelics provide a temporary and dramatic removal of the noise.

Mindfulness provides a daily, quieter, more sustainable access to the same territory.

The Twelve Steps — seriously engaged — provide a framework for bringing what is encountered in that territory into honest, accountable, living relationship with the actual fabric of one’s daily existence.

And beneath all of these practices, the same reality waits with the patience that only the eternal possesses: the reality of a consciousness that has never been broken, never been truly separate, never been as small as the wounded stories insisted.

That is what the opened door reveals. The life lived in alignment with that revelation — imperfect, ongoing, demanding, and sustaining — is the only worthy response to the gift.

Chapter 2002 (incomplete): The Doors of Perception — Psychedelics, the Sacred, and the Healing of a Wounded America

Then came industrialization, and with it, a peculiar narrowing of acceptable human experience.

What Psychedelics Actually Are — And What They Do

This is not incidental. It is, in many ways, the point.

The Entropic Brain: A New Framework for an Ancient Practice

“When we saw that certain behavioral characteristics of seizures actually improved in these mice, we were shocked to say the least,” said study author Brenden Rabinovitch.

The Ego and Its Discontents

Psychedelics, under the right conditions, open the cage.

The Personal Beginning: What the Body Knows Before the Mind Accepts

My most intense experience came from a variety of LSD called Orange Sunshine. Under its influence, the world became a living kaleidoscope — walls melting into streams of color, sounds braiding themselves into visual patterns, my entire psychological conditioning lifting away like smoke. What remained when the personality structure dissolved was not terror. It was witnessing. A pure, undifferentiated awareness observing the play of phenomena without the usual layer of identity filtering everything through its preferences and wounds. And in that state, something became luminously clear: that I had vastly more power over how I experienced reality — and other people — than I had ever been permitted to believe. The drug revealed not just an altered state but an expanded one. A glimpse of what the unconditioned human mind might actually be capable of when its crystallized structures momentarily fall away.

I stepped away from psychedelics in 1980. Not because the experiences had been without value — they had been among the most formative events of my life — but because the vessel they were being poured into had not yet been prepared. The last experience was difficult. It took two days to return to what I could recognize as myself, and for one of those days, I was genuinely uncertain the journey back was possible. The drugs had shown me everything they could show me at that stage of my development. The rest of the work would have to come from other disciplines.

And so, for more than four decades, that was how I lived — carrying the memory of those early doors as signposts, while building my interior life through meditation, recovery, mindfulness, and sustained contemplative practice. I carry no regret for the journeys taken. They were real. They showed me things that nothing else had shown me. And though I had found my way to similar territories through those other means, I recognized that for many people — perhaps most — such natural pathways are inaccessible without some initial loosening of the grip.

What I did not fully anticipate was that the journey was not finished with me.

The Return: October 2022 and the Psilocybin Retreat

In October of 2022, I attended a 14-hour spiritual retreat. It was the most powerful and transcendent experience I had encountered in many years — and it arrived not through the familiar disciplines of prayer or meditation, but through a return to the territory of plant medicine, approached this time with the full weight of decades of inner work behind it.

The facilitator administered to me psilocybin mushrooms in the form of a prepared elixir containing five different mushrooms and other herbs. She guided me into the altered state and witnessed me as I underwent the process of release from my egoic mind. I found myself losing all interest in the verbal dimension of my life experience, preferring instead to witness the world around me — and within me — with a total non-verbal, yet acutely conscious awareness. After three hours, I became verbal again.

She guided me through extensive personal sharing, and then responded to my answer to one of her questions about my perception of self-worth. She questioned me as to why I did not recognize myself as a beautiful person.

I replied that, though I know of my interior beauty and the beauty of my world, my body now shows to the world anything but that. I was in my late sixties at the time. I had psoriasis, skin cancer, wrinkles that Botox might address — and so my body image had kept me from acknowledging a truth the facilitator wanted me to see, and which my wife Sharon concurred with upon my return home.

I had long ago left behind that part of my biological and cultural self that sought a more perfect body in a quest to be attractive. My search had ended, in that regard, with Sharon having become my life partner since 1989. Yet I had forgotten to consciously cultivate my love for my body — and to express gratitude for the continued miracle of its existence as the vehicle for my version of consciousness.

The facilitator stated that if I only perceived my beauty to be an interior phenomenon, I was still just living out of my “head space,” as beauty is of the whole being — body, mind, and spirit — and a reflection of our connection with Mother Earth and the Universe. We are all of immeasurable beauty and significance, and these two qualities must forever remain within our hearts, independent of our biological, social, and personal agendas, and of the uninformed opinions of others. Otherwise, our failure to conform to the expectations of others will create internal informants who become our tricksters, and fool us into accepting disfigured visions and versions of the innate perfection of life.

That was quite a call upon me.

Marilyn “Masha” Feldman (2/29/1945 — 09/30/2019)

I remembered the times growing up when I felt rejected by most peers, sometimes because of my appearance. My wife reminded me of the time that Marsha Feldman — a pulchritudinous friend from the 1980s who has since passed — had rejected me as a lover because I did not have the classic handsome characteristics that her spoiled heart had demanded of all her previous lovers. I was not emotionally impacted by her assessment at the time, as I had little interest in sexual relationships then. I treasured her platonic friendship. Yet was the indifference I exhibited — and claimed for myself — only a facade? Was it an actual manifestation of some deeper denial, self-neglect, or even self-hatred?

Marsha had the most perfect body and face I had ever seen. Yet even she was not happy. She visited with her Rabbi several times, trying to get to the root of her unique problems. In addition to feeling out of harmony with life, she had an auto-immune disease and wanted her Rabbi to explain to her how she could find God and be healed of her suffering. Her Rabbi told her, quite succinctly, that he had wasted much of his own life searching for God through scripture and its laws, and had never found the Truth. It was not until he began an intense exploration of himself that he finally arrived at the doorstep of the Truth. He advised Marsha to learn about herself — her judgments against others and against herself. He told her she must explore the darkest corners and secrets of her life: her relationship to her body, her friends, her enemies, her family, her loves, her hatreds, her employment, and her connection with Nature. Marsha had to first see what “God” isn’t, to find the path to what “God” is.

Her Rabbi stressed that if Marsha was to find the healing balm that “God” could provide:

SHE HAD TO FIRST FIND HERSELF.

The Rabbi’s message is one for the ages and one for all of us. Marsha’s Rabbi recommended that even though she was not an alcoholic, she should try any twelve-step support group to begin exploration of her life at a deeper spiritual level. That is how I met her, at the 1987 International New Thought Alliance conference in Portland, at the talk given by the world-famous expert in twelve-step work and all-around motivational speaker, Jack Boland. He was a true master, and several years later at another Portland speaking engagement, he had the temerity to tell me that he probably knew me more than I knew myself. He stated that I needed more pain in my life to motivate me to want to dive deeper into my true self and recovery.

It has taken me a while, but I now realize that one of the dark forces that had dominated my early life continued to act as a subtle informant to my unconscious conspiracy of silence around my traumatic wounding — and my, as yet, failure to fully turn the dark black holes of negative influence from those early years into the light of the beauty of an infinite present moment experience.

Something that my mind now tells me is obvious was not so obvious before. The self-negating fact was so close, and so normalized historically, that I had accepted it and made it a foundation — an unconscious subroutine that supported an incomplete understanding of who I thought I was. I have an auto-immune disease.

I AM ATTACKING MYSELF

— through a false understanding of my body and its appearance to myself, and to others.

Should I have known better?

As I am an evolving consciousness, by remaining open to the wisdom of others, my own improving insight is enhanced and supported by other awakening souls and their compassionate feedback. Our collaborative insight helps all of us to see which part of ourselves to feed and support, and which parts to starve out of our awareness. Mindfulness and meditation help keep us connected to the “what is,” and the light of that awareness can bring transformative changes to the “seer” and to our “seeing.”

Another great insight was gained through the retreat and feedback process. While in my spiritually adjusted state — a state of higher consciousness — I was able to see, without judgment, one of my last remaining attachments to ego identification, other than to my body.

It was my body of writing.

The same judgment I had heaped upon myself for the state of my body, I was also heaping upon myself for the state of my writings. I saw how I had tried to bring my writings to the world in a way that was more presentable and readable by the general public. I had fallen ill to the need to cater to other people’s perceptions, rather than simply making my own best presentation and letting the chips fall where they may. In my most exalted state, I saw that my writings, just like my body, were suffering from an auto-immune disease — the disease where I permitted myself to attack myself for the failure of my self to make my appearance to others more pleasing.

The related and parallel idea that my face and my writings needed a kind of Botox treatment to be more presentable to others is an ongoing revelation. Yet I am in the process of transforming that darkness into the light of the present moment.

It is important that one fact still be entertained within my consciousness: my body and my writings are temporary containers for my infinite spiritual potential. As such, they were created to serve my Spirit as channels for its Infinite Expression, while my evolving consciousness and mindfulness keep me focused on that ultimate goal for my human expression and experience.

The Long Tradition: Psychedelics Through the Ages

In Mesoamerica, the Aztecs called psilocybin mushrooms teonanácatl — “flesh of the gods.” The Mazatec curandera María Sabina, who in 1955 permitted the first Westerner to participate in a mushroom ceremony, described the mushrooms themselves as speaking through her during healing rituals. They were not consumed recreationally. They were consulted. The distinction matters enormously.

The Healing of Meaning: What Depression Actually Is

The question is not whether these experiences are real. They are. The question is how to make them safely and responsibly accessible to the people who need them most.

Our country has been fed on spiritual and religious fast food for much too long. What is next in the queue for us?

Drive-through healing?
Five-minute meditations for transformation and prosperity?
New diets that guarantee weight loss and immortality?
Books that promise that all of your prayers will be answered if you would just pray the one special way offered by the starving author?
A magic pill that erases all difficult memories and creates pleasure where there once was only pain?

Or should we just declare “it is what it is,” throw up our hands in surrender, and accept defeat — or that all is “God’s will”?

There are no quick-fix solutions. True awakening requires depth, vulnerability, and a willingness to confront discomfort. Yet the evidence emerging from serious scientific research now confirms what the wisdom traditions always knew: that plant medicines, approached with proper intention, preparation, and guidance, offer a doorway into the genuine work of transformation — not a shortcut past it, but a legitimate threshold into it.

The American Context: Healing in an Age of Emptiness

But beyond the clinical data, something else is happening. People who undergo psychedelic-assisted therapy do not typically describe it as having their symptoms reduced. They describe it as

Chapter 2027: The Doors of Perception — Psychedelics, the Sacred, and the Healing of a Wounded America

Then came industrialization, and with it, a peculiar narrowing of acceptable human experience.

What Psychedelics Actually Are — And What They Do

This is not incidental. It is, in many ways, the point.

The Entropic Brain: A New Framework for an Ancient Practice

A landmark study published in Nature Communications demonstrated that a single 25mg dose of psilocybin produced measurable physical changes in the brain — denser neural tracts with greater structural integrity — that persisted for a full month after the experience. The brain, in other words, did not merely temporarily alter its function. It rebuilt itself. Participants showed improved performance on cognitive flexibility tests, elevated scores on measures of psychological wellbeing, and greater capacity for adaptive thinking. Those who experienced the greatest surge in brain entropy during their trip showed the most pronounced improvements. The intensity of the journey correlated directly with the depth of the healing.

“When we saw that certain behavioral characteristics of seizures actually improved in these mice, we were shocked to say the least,” said study author Brenden Rabinovitch.

The Ego and Its Discontents

Psychedelics, under the right conditions, open the cage.

William James, the great American psychologist and philosopher, argued in his 1902 classic The Varieties of Religious Experience that mystical states — regardless of how they are induced — share four defining characteristics: noetic quality (the sense of having gained genuine knowledge), ineffability (resistance to adequate verbal description), transience (they do not last), and passivity (the sense of being seized by something larger than oneself). The psychedelic experience reliably produces all four. This does not prove that psychedelic mystical experiences are genuine encounters with a transcendent reality. But it does suggest that dismissing them as mere chemical noise is philosophically naive.

The Personal Beginning: What the Body Knows Before the Mind Accepts

DMT came next, introduced to me by a man at a concert in Washington Park who called it “the businessman’s LSD” — a wry reference to its compressed duration. Where LSD stretched twelve hours across the membrane of consciousness, DMT folded the entire journey into two or three. Its effects were unlike anything I had encountered. Every stranger I encountered in those two hours felt intimately known to me. Not just friendly — known. I could sense something in them that transcended their surface personality, some deeper harmonic of goodwill and vulnerability that the ordinary social contract usually obscures. The fear of strangers, which had woven itself quietly through my young life, dissolved entirely. What replaced it was a sense of radical kinship — an experience that, I would later discover, is described in nearly identical terms by people who have taken the substance across every culture and demographic in which it has been studied.

I stopped using psychedelics in 1980. Not because the experiences had been without value — they had been among the most formative events of my life — but because the vessel they were being poured into had not yet been prepared. The last experience was difficult. It took two days to return to what I could recognize as myself, and for one of those days, I was genuinely uncertain the journey back was possible. The drugs had shown me everything they could show me at that stage of my development. The rest of the work would have to come from other disciplines.

I carry no regret for the journeys taken. They were real. They showed me things that nothing else had shown me. And though I have found my way to similar territories through meditation, mindfulness, and sustained spiritual practice, I recognize that for many people — perhaps most — such natural pathways are inaccessible without some initial loosening of the grip.

The Long Tradition: Psychedelics Through the Ages

The Healing of Meaning: What Depression Actually Is

Depression, in its deeper nature, is not merely a chemical imbalance. It is a crisis of meaning. It is the experience of being trapped — inside a body, inside a story, inside a self — with no apparent exit and no evident reason to endure the confinement. It is the ossification of possibility, the conviction that the future will be only a repetition of the past. The rigid ego is the vehicle of this entrapment. It maintains the prison through the relentless recycling of familiar thought-forms: I am not enough. I am fundamentally alone. The world is indifferent. Nothing will change.

The question is not whether these experiences are real. They are. The question is how to make them safely and responsibly accessible to the people who need them most.

The American Context: Healing in an Age of Emptiness

The Spiritual Dimension: What Science Cannot Fully Measure

The Frontier of Non-Hallucinogenic Neuroplasticity

“Even small chemical alterations to the structures of psychedelics have the potential to profoundly improve their safety and efficacy profiles,” said lead researcher David Olson.

In live animals, a single dose reversed brain damage induced by chronic stress and increased synapse density in the prefrontal cortex. If these results translate to human clinical settings, they suggest the possibility of treating severe neurological conditions — including schizophrenia, where cortical atrophy is a hallmark feature — with non-hallucinogenic psychedelic derivatives. This opens the possibility that the neurological benefits of psychedelic compounds could eventually be made available to populations who currently cannot access them safely. The molecule may be separable from the mystical experience it ordinarily accompanies — and both may have independent therapeutic value.

The Long Path and the Short Cut That Isn’t

My own path led me away from psychedelics and toward meditation, mindfulness, physical health, and genuine human connection as the primary vehicles of my continuing development. Not because the substances had nothing left to offer, but because the work they had begun required a different kind of attention to complete. The sacred silence they had introduced me to — that space of pure awareness beneath the chattering personality — could be accessed, more quietly and more durably, through disciplines that required no chemical assistance at all.

This is not an argument against psychedelic use. It is an argument for honesty about what they are. They are teachers. Powerful, potentially transformative teachers. But like all teachers, their value depends on the readiness of the student, the quality of the container in which the teaching occurs, and the willingness of the student to do the subsequent work.

A Final Word: The Silence Beneath the Noise

The real question is not whether they work. The evidence, historical and scientific, is overwhelming that they do.

That is not nothing. For many people, it is everything.

The work of healing — individual and collective — is always a long path. It requires integrity, sustained practice, honest relationships, and the willingness to encounter what we have most carefully avoided. Psychedelics do not replace that work. They do not offer the kind of salvation that can be purchased or swallowed without consequence. But they can open a door that had seemed permanently sealed. And for the soul in genuine crisis, that opening — however brief, however bewildering — can be the beginning of a return to life.

Chapter 2001: The Doors Within — Psychedelics, Consciousness, and the Long Road Home

There is a silence that lives beneath the noise of ordinary life. Most of us never find it. We are too busy, too anxious, too thoroughly convinced that the next acquisition, the next achievement, the next distraction will finally deliver us to the peace we have always suspected existed somewhere just beyond our grasp. American culture is particularly skilled at this kind of avoidance — constructing elaborate systems of busyness and consumption to paper over the aching void that so many carry quietly through their days. Depression rates climb. Suicide is a leading cause of death. Addiction tears through families and communities like a slow fire. And yet the dominant medical establishment continues to offer the same narrow toolkit: talk therapy, SSRIs, and the managing of symptoms rather than the transformation of their roots.

Something older knows better.

Long before clinical trials, before neuroscience mapped the serotonin receptor, before anyone coined the word “psychedelic,” human beings were using plant medicines to dissolve the boundaries of the ordinary self and enter into contact with something larger. They did so in the rainforests of the Amazon, in the ceremonial kivas of the American Southwest, in the mystery schools of ancient Greece. The shaman and the healer and the seeker all understood, through direct experience rather than hypothesis, that the mind was not a fixed and finished thing — that it could be opened, reorganized, and returned to itself in a form more fluid and alive than the one it had hardened into.

This chapter is an attempt to bring that ancient knowing into conversation with modern life. It is part personal testimony, part scientific inquiry, part philosophical reckoning. It does not offer false certainty, and it does not pretend that psychedelics are a simple solution to complex suffering. But it does argue, from both my lived experience and a growing body of rigorous research, that these substances hold extraordinary promise for healing — and that the culture’s long war against them has cost far more than it was ever willing to admit.

The Nature of Psychedelics: What They Are and What They Do

One of the most illuminating frameworks for understanding this process is the entropic brain hypothesis, developed by neuroscientist Robin Carhart-Harris. The concept borrows from physics, where entropy describes a state of randomness and disorder. In the context of the brain, higher entropy means the organ enters a less predictable, more dynamic state of operation. Our ordinary minds tend to run on deeply grooved patterns — habitual ways of thinking, rigid emotional responses, fixed narratives about who we are and what our lives mean. These patterns are efficient, but they can also become prisons. By increasing brain entropy, psychedelics dissolve these entrenched neural pathways, offering a temporary window of flexibility during which healthier patterns can be built in their place.

Recent neuroimaging research has made this process visible. A study published in Nature Communications followed 28 participants who received 25 milligrams of psilocybin — a full psychedelic dose. Within an hour of ingestion, researchers observed a dramatic rise in brain entropy. The brain, in other words, became capable of processing more information than usual, in more varied and less predictable configurations. More striking still: one month after the experience, participants’ brains showed denser neural tracts with greater structural integrity — the opposite of what is observed in the aging or traumatized brain.

“Psilocybin seems to loosen up stereotyped patterns of brain activity,” said Taylor Lyons, a research associate at Imperial College London, “and give people the ability to revise entrenched patterns of thought.”

Other research has mapped the more granular mechanics of this loosening. A team led by Paolo La-Torraca-Vittori at the University of Pavia found that LSD caused dramatic drops in local brain synchronization — particularly in areas responsible for processing vision and touch. Rather than operating in isolated, hierarchical clusters, the drug flattened the neural architecture, allowing the brain to broadly integrate sensory experience. This disrupts the default mode network, the brain system tied to self-referential thought and daydreaming, which is also the neurological home of the ego. When the default mode network is interrupted, people often report experiences of ego dissolution — the temporary loss of the sense of a separate, bounded self.

This is not incidental. It is, in many ways, the point.

The Ego and Its Discontents

The ego is not the enemy. This distinction matters enormously, and it is one that is often lost in conversations that romanticize dissolution without understanding what is being dissolved. The ego is a functional structure — it allows us to navigate social reality, maintain continuity across time, and take responsibility for our actions. The problem is not the ego’s existence but its calcification. When the ego hardens around trauma, around chronic shame, around the accumulated wounds of a difficult life, it stops being a useful organizing principle and becomes a cage.

Much of what presents as depression, anxiety, addiction, and existential despair is, at its core, a crisis of the rigid ego. The sufferer is trapped inside a story — about their own worthlessness, their inevitable failure, their fundamental separateness from love and meaning — that feels as immovable as concrete. Conventional talk therapy can illuminate these stories. It can name them, contextualize them, trace them back to their origins. But naming a cage is not the same as opening it.

Psychedelics, under the right conditions, open the cage. Ayahuasca — the brew of the Amazon prepared from the Banisteriopsis caapi vine and the Psychotria viridis leaf — has been described by those who have worked with it as “ten years of therapy in one night.” That description sounds like hyperbole until you understand what it means experientially: the dissolution of the rigid structures through which you ordinarily perceive yourself, followed by a direct encounter with the deeper, more fluid reality of your own psyche. People emerge from ceremonies describing forgiveness — of themselves and others — that years of conscious effort had failed to produce. They report a reconnection with the natural world, a renewed sense of kinship with other beings, a loosening of the grip of old grief.

This is not magic. It is neurochemistry meeting consciousness in a moment of extraordinary permeability.

A Personal Geography: Traveling Inside

I came to psychedelics the way many people of my generation did — not through clinical protocols or guided ceremonies, but through the casual, half-terrified experimentation of youth. My first encounter with LSD was in high school, a fraction of a tablet taken in careful secrecy before a bus ride into Portland. Even at that minimal dose, something shifted. Euphoria arrived, clean and total, without the cloudy edges of alcohol or the frantic edge of amphetamines. The world did not become strange — it became, for the first time, recognizable. There was a warmth in it. A sense of being continuous with the people around me rather than furtively separate from them. I thought I had discovered the promised land.

I was fifteen years old and had no framework for what I had experienced. But the memory of that opening stayed with me, a kind of luminous reference point that ordinary consciousness perpetually failed to return me to.

Later experiences grew more complex. DMT — called at the time “the businessman’s LSD” for its compressed two-to-three-hour duration — delivered something more disorienting: an annihilation of the fear of strangers, a sense of perfect transparent kinship with every person encountered during its brief reign. It was as though I could feel the goodness in people directly, without the usual defensive mediation of personality and projection. A more sober, lasting version of that experience came to me naturally fifteen years later, after genuine recovery from addiction and alcoholism. But the DMT had shown me the territory first — had demonstrated, with chemical certainty, that such a way of being was possible.

The Orange Sunshine LSD was another matter entirely. That phosphorescent orange tablet, secured at a summer concert in Delta Park, delivered an experience of total reality reorganization. The visual field became a living kaleidoscope, responsive and seemingly subject to the will. More profoundly, my “psychological set” — the accumulated conditioning of personality and habit — was temporarily evacuated. I found myself watching reality without the usual filters of who I had been taught to be. And in that naked witnessing, something became clear: I had far more agency in how I perceived my fellow human beings than I had ever understood. The experience was wild, disorienting, and, at its core, revelatory. I understood why figures like Timothy Leary and Ram Dass had devoted their lives to mapping this territory.

I stopped using psychedelics by 1980. The last LSD experience was difficult — a slow two-day return to ordinary consciousness that frightened me with the possibility it would never complete. I was never tempted to return. But I carry no regret for the journeys taken. They were real. They showed me things that nothing else had shown me. And though I have found my way to similar territories through meditation, mindfulness, and sustained spiritual practice, I recognize that for many people — perhaps most — such natural pathways are inaccessible without some initial loosening of the grip.

Ancient Wisdom and the Long Memory of Plant Medicine

What modern neuroscience is mapping, indigenous cultures have known for millennia.

The shaman’s role across cultures was not simply to administer a substance. It was to hold a container — a ritualized space of intention, safety, and interpretive wisdom — within which the traveler could navigate the dissolution of ordinary ego-consciousness and bring back something of value for the community. This is a crucial point that modern psychedelic research is only beginning to adequately appreciate: set and setting matter as much as the molecule itself. The psychological orientation with which a person approaches the experience, and the physical and relational environment in which it unfolds, shape what is possible at least as powerfully as the chemistry.

Nature, understood this way, is not merely a backdrop to human existence but an active healing intelligence. Plant medicines are her offering. As Deepak Chopra, Gabor Maté, and many other prominent healers have argued, the therapeutic potential of psychedelics is not a modern discovery — it is a modern rediscovery of something our ancestors knew and our culture systematically suppressed in its anxious drive toward rational control.

The word “psychedelic” itself — coined by psychiatrist Humphry Osmond in 1957, from the Greek for “mind-manifesting” — points toward this older understanding. These are not merely drugs in the pharmacological sense. They are instruments of revelation. They manifest what the mind already contains but cannot ordinarily access through the narrow aperture of everyday consciousness.

The Science of Healing: Depression, Addiction, and the Possibility of Change

Bill Wilson, the co-founder of Alcoholics Anonymous, had been sober from alcohol since 1935. By 1955, twenty years into his recovery, he was struggling with chronic depression that nothing — not sobriety, not fellowship, not the spiritual practice at the heart of the twelve steps — had managed to fully lift. That year, he began a series of sessions with LSD under therapeutic supervision. He believed the substance could provide access to the kind of transformative spiritual experience that had originally powered his recovery — and that it might offer similar access to those for whom conventional AA pathways to spiritual experience remained closed.

Wilson’s intuition was decades ahead of the clinical infrastructure needed to test it properly. But contemporary research is now building exactly that infrastructure, and the findings are striking.

A large-scale analysis published in the Journal of Psychoactive Drugs pooled survey data from nearly 140,000 American adults. After controlling for age, income, education, and use of other substances, researchers found that adults who had used LSD in the past year were 30 percent less likely to meet the diagnostic criteria for alcohol use disorder. Among those who did have the disorder, recent users reported approximately 15 percent fewer symptoms overall. Other popular substances — ketamine, MDMA — did not show equivalent associations. The authors suggest that the psychological shifts commonly reported by LSD users, including increased openness and decreased neuroticism, may reduce the underlying mental architecture that drives heavy drinking.

The data on depression is equally compelling. James Glazer and colleagues at Northwestern University administered a 26-microgram dose of LSD — sub-hallucinogenic, chosen specifically to avoid the intensity of a full trip — to participants with mild depression. They then tracked brain electrical activity while participants played a computerized reward game. In ordinary depressed individuals, the brain shows a characteristic “blunting” of emotional response — a diminished reaction to both winning and losing that drains motivation and impairs the capacity to learn from experience. Under the low LSD dose, this blunted response normalized dramatically: the gap between the emotional weight of winning and losing widened, indicating a restoration of healthy reward processing. Volunteers who showed the strongest neural shift also reported the most significant improvements in positive mood — and these improvements persisted for two days after the session, long after the drug itself had cleared their systems.

A separate trial, published in Progress in Neuropsychopharmacology & Biological Psychiatry, enrolled nineteen adults with major depression in an eight-week microdosing protocol. Participants took liquid LSD sublingually twice a week and tracked their mood, sleep, and daily function through a smartphone application. On the days they consumed the microdose, they reported higher levels of energy, creativity, and social connection. They felt happier and less irritable on the two following days as well. By the end of the eight weeks, formal clinical interviews showed an average 60 percent drop in depression severity across the group — a number that would be extraordinary for any pharmaceutical intervention. Crucially, participants showed no tolerance buildup over the eight weeks: the drug did not need to be continually increased to maintain its effect.

The neuroplasticity research adds another dimension. A team at the University of California, Davis engineered a new compound called JRT — a modified analogue of LSD in which the position of exactly two atoms was flipped, removing the molecule’s hallucinogenic properties while preserving its capacity to promote neuroplasticity. In laboratory tests, JRT promoted substantial growth in dendritic branches — the connective extensions of neurons — exceeding even the performance of LSD itself. In live animals, a single dose reversed brain damage induced by chronic stress and increased synapse density in the prefrontal cortex. If these results translate to human clinical settings, they suggest the possibility of treating severe neurological conditions — including schizophrenia, where cortical atrophy is a hallmark feature — with non-hallucinogenic psychedelic derivatives.

Even the seizure research is startling in its implications. A University of Toronto team, initially testing LSD to ensure it wouldn’t worsen epilepsy in patients who might also have functional seizures, found the exact opposite of what they feared: in a mouse model of severe seizures induced by kainic acid, nearly 40 percent of untreated male mice entered life-threatening status epilepticus. Among those treated with LSD, the rate dropped to zero. None died. The drug appeared to introduce sufficient neural noise — the very entropy that defines the psychedelic state — to prevent the hypersynchronized electrical cascades that constitute seizure activity.

“When we saw that certain behavioural characteristics of seizures actually improved in these mice,” said study author Brenden Rabinovitch, “we were shocked to say the least.”

The Healing of Meaning: What Depression Actually Is

The data is important. But data alone does not capture what is at stake in this conversation, particularly for Americans navigating an existence that offers unprecedented material comfort alongside epidemic-level rates of loneliness, purposelessness, and despair.

Depression, in its deeper nature, is not merely a chemical imbalance. It is a crisis of meaning. It is the experience of being trapped — inside a body, inside a story, inside a self — with no apparent exit and no evident reason to endure the confinement. It is the ossification of possibility, the conviction that the future will be only a repetition of the past. The rigid ego, discussed earlier, is the vehicle of this entrapment. It maintains the prison through the relentless recycling of familiar thought-forms: I am not enough. I am fundamentally alone. The world is indifferent. Nothing will change.

This is what people mean when they describe ayahuasca as ten years of therapy in one night. Not that insights are delivered effortlessly, but that the habitual structures that ordinarily prevent insight are temporarily suspended, allowing the deeper intelligence of the psyche to speak. As psychologist Rachel Allyn has written, ayahuasca works by dialing down the default mode network — the neurological home of the ego — and in doing so, it can free people from the dysfunctional aspects of ego-consciousness that hold them locked in self-defeating patterns. Many people who have sat in ceremony report experiences of profound self-forgiveness, of grief finally released, of reconnection with a sense of purpose that had been buried under years of compensatory behavior.

The question is not whether these experiences are real. They are. The question is how to make them safely and responsibly accessible to the people who need them most.

The Path Forward: Integration, Responsibility, and Promise

The risks associated with full psychedelic experiences — particularly for individuals with personal or family histories of psychosis or schizophrenia — are genuine and must be taken seriously. The non-hallucinogenic analogue JRT represents one promising direction for making the neuroplasticity benefits of psychedelics available without the attendant risks of ego dissolution for vulnerable populations. But that work is still in its early stages.

And the matter of integration — what happens after the experience — cannot be overstated. A psychedelic journey can dissolve rigid patterns and open new psychological territory. But the work of building durable new habits, relationships, and ways of being in that newly opened territory requires sustained effort, skilled support, and time. The experience is not the cure. It is the opening through which cure becomes possible.

For those who approach psychedelics with a chaotic mindset, with unprocessed trauma close to the surface and no container of support around the experience, the outcome can be destabilizing rather than liberating. This is not an argument against psychedelics — it is an argument for doing them right. The shaman’s wisdom was not just about the plant. It was about the preparation, the ceremony, the community, and the integration of what was encountered. Modern therapeutic protocols are, at their best, attempting to reconstruct that container within a clinical framework.

Bill Wilson knew it. Timothy Leary knew it, however chaotically he broadcast it. Ram Dass, who spent decades pointing toward the same liberation through gentler means, understood that for some people, the plant medicines offer access to territories of consciousness that would otherwise remain forever closed to them. Gabor Maté, one of the most respected trauma researchers and clinicians in the world, has written and spoken at length about the healing potential of ayahuasca and other psychedelic medicines, particularly for those whose suffering is rooted in early relational trauma.

The promise is real. The frontier is open. And the human beings who suffer — who carry their grief and shame and meaninglessness through the loud machinery of American daily life, seeking relief in the same consumptions that produced their emptiness — deserve every tool that honest inquiry can offer them.

A Final Word: The Silence Beneath the Noise

That is not nothing. For many people, it is everything.

The work of healing — individual and collective — is always a long path. It requires integrity, sustained practice, honest relationships, and the willingness to encounter what we have most carefully avoided. Psychedelics do not replace that work. They do not offer the kind of salvation that can be purchased or swallowed without consequence. But they can open a door that had seemed permanently sealed. And for the soul in genuine crisis, that opening — however brief, however bewildering — can be the beginning of a return to life.

Chapter 2026: The Doors of Perception — Psychedelics, the Sacred, and the Healing of a Wounded America

There is a particular kind of silence that descends after a profound experience. Not the silence of emptiness, but the silence of saturation—a mind so full of what it has witnessed that ordinary language temporarily fails. Those who have traveled deep into a psychedelic experience know this silence intimately. They return from it changed in ways that resist easy description, carrying fragments of understanding that feel simultaneously ancient and radically new.

The psychedelic experience is not a modern invention, despite how aggressively modern culture has tried to either pathologize or commercialize it. Human beings have been deliberately altering their consciousness through plant medicine for tens of thousands of years. The Mazatec shamans of Oaxaca have worked with psilocybin mushrooms since long before recorded history. The indigenous peoples of the Amazon basin have brewed ayahuasca—a potent combination of Banisteriopsis caapi vine and DMT-containing plants—for ceremonial, healing, and spiritual purposes stretching back millennia. The ancient Greeks conducted the Eleusinian Mysteries, a sacred initiation ritual believed by many scholars to have involved a psychedelic brew called kykeon. For most of human history, the deliberate dissolution of ordinary consciousness was not a fringe activity. It was often the most sacred act a culture could engage in.

Then came industrialization, and with it, a peculiar narrowing of acceptable human experience.

This chapter is an attempt to hold several threads together at once: the personal, the historical, the scientific, and the spiritual. It does not pretend to offer final conclusions. The psychedelic experience, almost by definition, resists finality. What it offers instead is a more honest reckoning with what these substances are, what they have meant across time and cultures, what science is now confirming about their mechanisms, and why—at this particular moment in American history—so many people are turning toward them not as an escape from life, but as a doorway back into it.

The Personal Beginning: What the Body Knows Before the Mind Accepts

What arrived an hour later was nothing short of an internal revolution. A wave of euphoria so clean and so complete that it felt less like a chemical event and more like a homecoming. Peace arrived. Love for strangers arrived. The library’s quiet hum took on a texture and warmth I had never noticed. At fifteen, having never experienced anything of this quality before, I made the mistake of believing I had found the promised land. I had not. But I had found a door—and the knowledge that such a door existed would shape every serious inquiry I would pursue for the rest of my life.

DMT came next, introduced to me by a man at a concert in Washington Park who called it “the businessman’s LSD”—a wry reference to its compressed duration. Where LSD stretched twelve hours across the membrane of consciousness, DMT folded the entire journey into two or three. Its effects were unlike anything I had encountered. Every stranger I encountered in those two hours felt intimately known to me. Not just friendly—known. I could sense something in them that transcended their surface personality, some deeper harmonic of goodwill and vulnerability that the ordinary social contract usually obscures. The fear of strangers, which had woven itself quietly through my young life, dissolved entirely. What replaced it was a sense of radical kinship—an experience that, I would later discover, is described in nearly identical terms by people who have taken the substance across every culture and demographic in which it has been studied.

Later, during a senior year LSD experience shared with two friends, something stranger occurred. Marc and I began seeing the same hallucinations simultaneously—precisely the same images, arising and shifting in synchrony. When Mike, our host, appeared to both of us as a grinning devil—red horns, crimson face, serpentine tail—we collapsed in laughter that lasted ten minutes. Mike could not see what we saw. This simultaneous shared vision suggested something about the psychedelic state that the pharmaceutical model of consciousness struggles to accommodate: that these substances may, under the right conditions, facilitate a kind of interpersonal permeability that transcends the usual boundaries of individual subjective experience.

My most intense experience came from a variety of LSD called Orange Sunshine. Under its influence, the world became a living kaleidoscope—walls melting into streams of color, sounds braiding themselves into visual patterns, my entire psychological conditioning lifting away like smoke. What remained when the personality structure dissolved was not terror. It was witnessing. A pure, undifferentiated awareness observing the play of phenomena without the usual layer of identity filtering everything through its preferences and wounds. And in that state, something became luminously clear: that I had vastly more power over how I experienced reality—and other people—than I had ever been permitted to believe. The drug revealed not just an altered state but an expanded one. A glimpse of what the unconditioned human mind might actually be capable of when its crystallized structures momentarily fall away.

I stopped using psychedelics in 1980. Not because the experiences had been without value—they had been among the most formative events of my life—but because the vessel they were being poured into had not yet been prepared. The last experience was difficult. It took two days to return to what I could recognize as myself, and for one of those days, I was genuinely uncertain the journey back was possible. The drugs had shown me everything they could show me at that stage of my development. The rest of the work would have to come from other disciplines.

The Long Tradition: Psychedelics Through the Ages

To treat psychedelics as a 1960s phenomenon is to misunderstand them at the most fundamental level. Human beings have always reached for altered states of consciousness. The question is not whether this reaching is natural—it clearly is—but whether the reaching is purposeful, prepared, and integrated into a larger framework of meaning.

The Eleusinian Mysteries, conducted annually for nearly two thousand years in ancient Greece, initiated participants—including Plato, Aristotle, and Cicero—into experiences they described as the most significant of their lives. Initiates took a solemn oath never to fully describe what they witnessed, and largely kept it. What they did report was a complete dissolution of the fear of death, a direct encounter with what Greek culture called the divine, and a transformation of how they understood the relationship between individual life and the cosmic whole. The classicist Carl Ruck and mycologist R. Gordon Wasson have made compelling arguments that the kykeon—the ceremonial drink consumed at Eleusis—contained ergot, a fungus that grows on grain and produces compounds chemically related to LSD.

In Mesoamerica, the Aztecs called psilocybin mushrooms teonanácatl—”flesh of the gods.” The Mazatec curandera María Sabina, who in 1955 permitted the first Westerner to participate in a mushroom ceremony, described the mushrooms themselves as speaking through her during healing rituals. They were not consumed recreationally. They were consulted. The distinction matters enormously.

In the Amazon, ayahuasca is understood by the indigenous communities that use it not merely as a plant medicine but as a teacher—an intelligence that exists within the natural world and communicates through the altered state. Sessions are conducted by trained healers called curanderos or ayahuasceros, who spend years learning how to hold the space for participants and navigate the terrifying and beautiful terrain the medicine opens. The integration of the experience into daily life is considered as important as the experience itself.

This context—of ritual, preparation, trained guidance, and integration—is what distinguished traditional psychedelic use from the chaotic recreational experimentation of the twentieth century. When Timothy Leary urged millions of young Americans to “turn on, tune in, drop out” with little guidance, little preparation, and no cultural container capable of holding what was released, the results were predictably mixed. Some people had genuinely transformative experiences. Others were psychologically undone by them. The tragedy was not the substances themselves, but the absence of the wisdom traditions that had always accompanied their use.

The Neuroscience of Wonder: What Happens Inside the Brain

The entropic brain hypothesis—articulated by neuroscientist Robin Carhart-Harris and his colleagues at Imperial College London—offers the most rigorous scientific framework currently available for understanding what psychedelics actually do to the brain. In physics, entropy refers to a measure of disorder or randomness. In neuroscience, Carhart-Harris proposed that higher brain entropy corresponds to a more flexible, less predictable, more creative state of neural activity.

The ordinary brain operates in highly efficient but deeply habitual patterns. The default mode network—a constellation of brain regions that activates during self-reflection, rumination, and mind-wandering—tends to act as the enforcer of these patterns. It is, in a sense, the neurological address of the ego: the system that generates and maintains our ongoing narrative about who we are, what we deserve, what threatens us, and what is possible. In depression, trauma, and addiction, this network often becomes pathologically overactive—running the same loops of negative self-assessment, shame, and fear on constant repeat, like a broken record that cannot be lifted.

Psychedelics interrupt the default mode network with extraordinary force. Brain imaging studies show that psilocybin, LSD, and ayahuasca all dramatically reduce the activity and internal coherence of this network. As it quiets, something else emerges: a broader, more integrated pattern of connectivity across brain regions that do not normally communicate with each other. The walls between perceptual, emotional, and cognitive systems dissolve. The result is what researchers call increased brain entropy—a state in which the brain is operating with greater flexibility, creativity, and openness to new information.

A landmark study published in Nature Communications demonstrated that a single 25mg dose of psilocybin produced measurable physical changes in the brain—denser neural tracts with greater structural integrity—that persisted for a full month after the experience. The brain, in other words, did not merely temporarily alter its function. It rebuilt itself. Participants showed improved performance on cognitive flexibility tests, elevated scores on measures of psychological wellbeing, and greater capacity for adaptive thinking. Those who experienced the greatest surge in brain entropy during their trip showed the most pronounced improvements. The intensity of the journey correlated directly with the depth of the healing.

The mechanism is becoming clearer. LSD works primarily by binding to serotonin receptors in the brain—the same receptors targeted by standard antidepressants, but with an entirely different pharmacological profile. Research led by Lingyu Zhang at the Beijing University of Posts and Telecommunications revealed that LSD dramatically shifts the balance between excitatory and inhibitory neurons, suppressing the brain’s sensory anchors while liberating its capacity for abstract thought. The biological brakes come off in precisely the regions that generate meaning, insight, and perspective—allowing the mind to make connections it could not have made while constrained within its habitual architecture.

Work led by James Glazer at Northwestern University found that even very low, sub-hallucinogenic doses of LSD—doses carefully calibrated to alter brain function without producing visual hallucinations—restored normal reward processing in individuals with mild depression. Depression characteristically flattens the brain’s response to positive outcomes, making winning, receiving, and succeeding feel hollow. The low dose of LSD temporarily reversed this flattening, generating robust emotional responses to negative feedback—a sign that the brain was re-engaging with reality with its full motivational range. Participants who showed the strongest neural response also reported the highest improvements in mood, and these improvements lingered for two days after the laboratory session.

A pilot microdosing study conducted at the University of Auckland by Dimitri Daldegan-Bueno and his colleagues enrolled 19 adults with major depressive disorder. Participants microdosed LSD twice weekly for eight weeks, using a smartphone application to track their sleep, mood, and daily functioning. On dosing days, they reported elevated energy, creativity, and social connection. On the two days following each dose, they felt happier and less irritable. Crucially, they reported no tolerance over the eight weeks—no need to increase the dose to maintain the effect, which sets psychedelics apart from nearly every other pharmacological intervention in psychiatry. At the end of the trial, a formal clinical interview revealed an average reduction in depression severity of sixty percent across the group.

Even more unexpected was recent research from the University of Toronto, where a team testing LSD in a mouse model of severe seizures discovered that the drug appeared to have powerful neuroprotective properties. In control animals exposed to a seizure-inducing compound, nearly forty percent of male mice entered life-threatening continuous seizure states. In mice pretreated with LSD, this did not happen at all. The researchers, who had begun the project as a simple safety study, were shocked by what they found. “When we saw that certain behavioral characteristics of seizures actually improved in these mice, we were shocked to say the least,” said study author Brenden Rabinovitch. The entropic, chaotic patterns of electrical activity generated by the drug appeared to make it neurologically impossible for the rigid, hyper synchronized electrical cascades of a severe seizure to organize and propagate.

This opens a genuinely new frontier. If psychedelics can protect the brain from the most violent electrical events it experiences, what else might they be protecting us from? What other kinds of pathological rigidity—cognitive, emotional, social—might their controlled application help to dissolve?

The Spiritual Dimension: What the Scientists Cannot Fully Measure

Science is extraordinarily good at describing mechanisms. It can tell us which receptors are bound, which brain networks are suppressed, which electrical patterns emerge. What it is less equipped to address is the content of the psychedelic experience itself—and for millions of people across thousands of years, that content has been primarily spiritual in nature.

The dissolution of the default mode network correlates with what the mystics of every tradition have called ego death—the temporary cessation of the ordinary sense of being a separate, bounded self. When this happens, the question of what remains is the oldest question in philosophy. Hindu tradition calls it Atman—the universal self, identical with the ground of all being. Buddhist tradition calls it sunyata—emptiness, the recognition that the self was always a construction rather than a fundamental reality. Christian mysticism, in its more contemplative streams, describes it as union with God—a direct experiential encounter with the divine that transcends all doctrinal formulation.

William James, the great American psychologist and philosopher, argued in his 1902 classic The Varieties of Religious Experience that mystical states—regardless of how they are induced—share four defining characteristics: noetic quality (the sense of having gained genuine knowledge), ineffability (resistance to adequate verbal description), transience (they do not last), and passivity (the sense of being seized by something larger than oneself). The psychedelic experience reliably produces all four. This does not prove that psychedelic mystical experiences are genuine encounters with a transcendent reality. But it does suggest that dismissing them as mere chemical noise is philosophically naive.

Bill Wilson, the co-founder of Alcoholics Anonymous, understood this intuitively. Twenty years into his own recovery from alcoholism, suffering from chronic depression that sobriety alone could not lift, Wilson began experimenting with psychedelic therapy in 1955. He believed—based on direct experience—that the spiritual awakening he had undergone in the 1930s, which had freed him from addiction, could be made available to others through psychedelic-assisted therapy. He was particularly interested in reaching those who, despite their sincere desire for recovery, could not access the felt sense of a higher power through conventional means.

This insight has found its fullest modern expression in the work of researchers at Johns Hopkins University and NYU, who have demonstrated that psilocybin-assisted therapy produces mystical experiences in the majority of participants—and that the intensity of the mystical experience is the single strongest predictor of therapeutic outcome. People who report feeling a profound sense of unity, love, and connection during their session show the greatest long-term reductions in depression, anxiety, and addiction. The spiritual and the therapeutic are not separate dimensions. They appear to be the same thing, approached from different angles.

Deepak Chopra, Gabor Maté, Dick Schwartz—some of the most respected voices in integrative medicine and trauma therapy—have all recognized the therapeutic and spiritual potential of psychedelic-assisted work. Maté, whose work on trauma and addiction has reached millions of readers, has participated in and facilitated ayahuasca ceremonies, and describes them as among the most powerful healing interventions he has encountered in a long career. Schwartz, the developer of Internal Family Systems therapy, has observed that psychedelics appear to create rapid and lasting access to what he calls the Self—the compassionate, curious, centered core of human identity that trauma has buried under layers of defensive reaction.

Indigenous peoples knew all of this. They did not need clinical trials to tell them that plant medicines could dissolve the fear of death, heal the wounded psyche, and restore a sense of connection to something larger than the individual ego. They had been observing these effects, developing protocols for working with them, and transmitting that knowledge through lineages of trained healers for hundreds of generations. The modern psychedelic renaissance does not represent the discovery of something new. It represents the slow, halting return of Western culture to something very old—something that was never lost, only deliberately forgotten.

The American Context: Healing in an Age of Emptiness

America has a particular kind of wound. It is not a wound of poverty alone, or violence alone, or inequality alone—though all of these are real and serious. It is the wound of disconnection. A culture organized around consumption and competition produces citizens who are extraordinarily productive and extraordinarily lonely. The rates of depression, anxiety, addiction, and suicide in the United States are not incidental to its social organization. They are expressions of it.

Nearly a third of American adults report symptoms consistent with a diagnosable anxiety or depressive disorder. Overdose deaths continue to mount, each one representing not simply a failed intervention but a life that found no adequate reason to remain. The opioid crisis—which began as a pharmaceutical marketing campaign and metastasized into a national catastrophe—is best understood as a mass attempt to medicate a pain that is not purely biological. It is existential. People are reaching for something. They are trying to feel something, or to stop feeling something, or to find some brief respite from a life that offers sensation without meaning, stimulation without depth, connection without intimacy.

Conventional psychiatry offers partial answers. Antidepressants help many people. Talk therapy helps many people. But the blunting of emotional pain through pharmaceutical management is not the same as the restoration of meaning. A quieter depression is still a depression. And for the growing number of Americans whose conditions resist conventional treatment—estimated at thirty to forty percent of those with major depressive disorder—the current pharmacological toolkit has essentially run out of options.

Research on psilocybin for treatment-resistant depression has produced response rates that dwarf those of conventional antidepressants. Studies at Johns Hopkins, NYU, and Imperial College London have demonstrated lasting reductions in depression and anxiety after one or two guided sessions with psilocybin—effects that persist for months and sometimes years. MDMA-assisted psychotherapy for PTSD has shown response rates so strong that the FDA granted it Breakthrough Therapy designation. Ketamine—already legal and in clinical use—is demonstrating rapid anti-suicidal effects that no other intervention can reliably achieve.

But beyond the clinical data, something else is happening. People who undergo psychedelic-assisted therapy do not typically describe it as having their symptoms reduced. They describe it as having recovered something they did not know they had lost—a connection to their own aliveness, a sense of being part of something larger than their personal history, a capacity for wonder that anxiety and depression had gradually strangled. These are not small gains. These are the gains that make a life worth living.

Research by James M. Zech at Florida State University, analyzing federal health data from nearly 140,000 American adults, found that people who had used LSD in the past year were thirty percent less likely to meet diagnostic criteria for alcohol use disorder than non-users. Among those who did have the disorder, recent users reported fifteen percent fewer symptoms. The psychological shifts associated with LSD—increased openness, reduced neuroticism, a wider sense of perspective—appear to chip away at the psychological architecture of addiction from the inside.

The Promise and the Responsibility

The wisdom traditions understood this. They did not hand ayahuasca to strangers at parties. They built elaborate protocols of dietary preparation, psychological readiness, experienced guidance, and communal support. They understood that the journey is only half of the medicine—that what you do with what you see, in the weeks and months after the experience, determines whether the door that was opened leads somewhere or simply leaves you exposed to the elements.

Scientists at the University of California, Davis have taken this further still—engineering a chemical analogue of LSD called JRT, which preserves the drug’s extraordinary capacity to promote neuroplasticity (the growth and repair of neural connections) while removing the hallucinogenic component entirely. In laboratory studies, JRT promoted substantial growth in dendritic branches—the neural structures through which brain cells communicate—exceeding even the performance of the original compound. It reversed brain damage induced by chronic stress. It improved cognitive flexibility. And it did all of this without producing the perceptual alterations that make full psychedelic experiences therapeutically risky for certain populations.

“Even small chemical alterations to the structures of psychedelics have the potential to profoundly improve their safety and efficacy profiles,” said lead researcher David Olson. This opens the possibility that the neurological benefits of psychedelic compounds could eventually be made available to populations—including those with schizophrenia risk factors—who currently cannot access them safely.

The Long Path and the Short Cut That Isn’t

My own path led me away from psychedelics and toward meditation, mindfulness, physical health, and genuine human connection as the primary vehicles of my continuing development. Not because the substances had nothing left to offer, but because the work they had begun required a different kind of attention to complete. The sacred silence they had introduced me to—that space of pure awareness beneath the chattering personality—could be accessed, more quietly and more durably, through disciplines that required no chemical assistance at all.

What is clear is this: the substances that human beings have been using for thousands of years to dissolve the illusion of separateness, to encounter the sacred, to heal the wounded mind, and to restore the felt sense of meaning to a life that had lost it—these substances are not the enemy. They are, if anything, among the oldest allies the human species has. The real question is not whether they work. The evidence, historical and scientific, is overwhelming that they do.

The real question is whether we are ready to work with them—honestly, carefully, humbly, and with the full weight of responsibility that accompanies any genuine encounter with the depths of the human mind.

apter 2000: LSD and Others.

Recent scientific exploration into psychedelics provides evidence that these powerful substances can profoundly reshape human brain function and mental health. A wave of new research suggests that lysergic acid diethylamide, widely known as LSD, alters electrical brain rhythms to promote mental flexibility, elevate mood, and even protect against neurological damage. These discoveries point to an expanding medical frontier where altered states of consciousness might translate into targeted treatments for conditions ranging from depression to alcohol addiction.

Psychiatric and neurological disorders affect hundreds of millions of people globally, often causing immense personal and societal disruption. Conditions like major depressive disorder, alcohol use disorder, and severe epilepsy frequently resist conventional treatments. This leaves many patients with limited medical options and a poor quality of life. This unmet medical need has prompted a renewed focus on classic psychedelics as potential therapeutic agents.

Drugs like LSD produce intense shifts in perception, mood, and cognitive processing. They achieve this primarily by binding to serotonin receptors in the brain. Receptors are specialized protein structures on the surface of brain cells that receive chemical signals to trigger biological responses. When a psychedelic chemical locks into these receptors, it initiates a cascade of neurochemical events that changes how different brain regions communicate with one ano

Scientists explore these mechanisms to understand exactly how psychedelics disrupt rigid mental habits. The entropic brain hypothesis serves as a guiding concept in much of this work. In physics, entropy refers to a state of randomness and disorder. In neuroscience, higher entropy means the brain enters a less predictable, more dynamic state of operation. By increasing brain entropy, psychedelics might dissolve entrenched neural patterns, offering temporary flexibility that helps patients build healthier mental habits.

Mapping Local Brain Disruptions

To understand how LSD alters consciousness, a research team examined its effects on tiny, localized clusters of brain cells. Paolo La-Torraca-Vittori, a researcher at the University of Pavia, and Livio Tarchi of the University of Florence led the project, which was published in the European Journal of Neuroscience. The authors wanted to map how the drug influences spontaneous brain waves and local electrical synchronization in resting adults.

The team analyzed an open-access database containing brain scans of 15 healthy adults. Each participant received an intravenous placebo on one day and a moderate dose of LSD on another day. The researchers measured the amplitude of low-frequency fluctuations, a metric that tracks the power of slow brain waves in a specific area. They also measured regional homogeneity, which assesses how well neighboring brain cells synchronize their electrical firing.

Under the influence of the drug, both metrics dropped significantly across the cortex. This suggests that local brain activity became faster, noisier, and less synchronized. The researchers noted that these drops were especially pronounced in areas that process vision and incoming physical touch. This localized fragmentation forces the brain to abandon its normal hierarchical structure, where sensory data is processed in specialized silos before moving up to associative regions.

Instead of operating in isolated clusters, the drug flattens the neural hierarchy, allowing the brain to broadly integrate visual and physical sensations. The study also highlighted disruptions in the default mode network, a brain system tied to daydreaming and self-reflection. Disruptions in this network tend to correlate with the loss of a defined conscious self, a common psychological experience reported by people using psychedelics.

The authors mapped these physical brain changes against the known locations of various chemical receptors. They found that the desynchronization patterns strongly mirrored the distribution of dopamine receptors and alternative serotonin receptors, expanding the assumed primary targets of the drug. Brain areas with fewer of these specific receptors experienced the greatest decreases in local synchronization, indicating a complex biological interaction.

Shifting the Balance of Excitement and Inhibition

Another recent project built on similar brain scanning data to explore how LSD bridges the gap between basic perception and abstract thought. Lingyu Zhang, a researcher at the Beijing University of Posts and Telecommunications, led the analysis. The research, published in PLOS Computational Biology, paired brain scans with advanced computer modeling to estimate internal chemical shifts.

Healthy brain function operates on a delicate balance between excitatory neurons and inhibitory neurons. Excitatory neurons act like biological accelerators that encourage brain cells to fire, while inhibitory neurons act like brakes to keep the system organized. Zhang and the research team built a dynamic computer simulation to estimate how this chemical balance changes across the cerebral cortex, the brain’s wrinkled outer layer.

The computer model estimated a sharp drop in the excitatory-to-inhibitory ratio within sensory and motor processing regions. This means the biological brakes became much stronger in areas dealing with basic sensory input. On the flip side, the activation ratio increased in abstract associative regions, essentially taking off the brakes and making those neurons highly active.

By suppressing sensory anchors and boosting abstract thought, the drug blurs the boundaries that usually separate physical perception from internal cognition. The research team also looked for patterns of global synchronization, measuring when rhythmic waves of activity aligned across different brain networks. They found that the drug enhanced global synchrony, pulling the brain out of its segregated, independent routines and into a unified firing state.

This physiological shift provides evidence for how the substance fosters cognitive flexibility. The authors suggest that this neural remodeling aligns closely with subjective reports of intense introspection and an altered perception of the physical world. The drug binds to specific serotonin receptors, which then manipulate the primary excitatory neurotransmitters in the sensory cortex, sending a ripple effect across the entire mind.

Altering Emotional Responses with Low Doses

Scientists are also exploring whether tiny, sub-hallucinogenic amounts of psychedelics can produce beneficial neurological changes. James Glazer, a researcher in the Department of Psychiatry at Northwestern University, led a project testing how low doses alter the way the brain processes emotional rewards. The findings were published in the Journal of Psychopharmacology.

People experiencing depression often show a blunted capacity to process rewards, meaning their brains do not react strongly to winning or receiving positive feedback. This stunted emotional processing can drain motivation and make it difficult to learn from mistakes. The research team set out to determine if a low dose of the drug could normalize this altered reward processing in individuals with mild depression.

The experiment involved 34 healthy volunteers who reported varying levels of depressed mood on standard psychological questionnaires. Each person attended two sessions, receiving either a 26-microgram dose of LSD or an inactive placebo. This low dose was specifically chosen to alter basic brain function without inducing intense visual hallucinations that could interfere with taking a test.

During the sessions, the volunteers played a computerized game that offered small monetary rewards for quick reactions. As they played, researchers tracked their real-time brain waves using electroencephalography, a technique that records electrical signals from sensors placed over the scalp. They focused on a prolonged electrical wave that reflects the deep emotional value of an outcome, which typically corresponds with activation in the amygdala.

The amygdala is a tiny structure deep in the brain that regulates emotional processing. In healthy brains, losing a game triggers a massive electrical spike in this region that dwarfs the reaction to winning, driving the person to adapt and focus harder. During the placebo session, participants with higher depression levels showed a stunted electrical response to losing the game, fitting the classic profile of depressive blunting.

When given the active drug, this biological dynamic shifted significantly. The substance widened the gap between losing and winning scenarios for these individuals, generating a much larger emotional response to negative feedback. This suggests the drug temporarily restored a more typical, robust neural reaction to missed rewards.

This electrical shift directly mirrored the subjective experiences of the participants. Volunteers who showed the strongest neural increase also reported the highest improvements in positive mood during the active session. This elevated emotional state lingered, with those participants reporting lower overall depressed mood two days after the laboratory visit.

Tracking Mood Elevations Through Microdosing

Building on the concept of low doses, a separate team tested a frequent microdosing schedule for individuals with major depressive disorder. Dimitri Daldegan-Bueno, a pharmacy researcher at the University of Auckland, led the pilot project published in Progress in Neuropsychopharmacology & Biological Psychiatry. The scientists wanted to see if acute mood improvements occurred in a clinical population practicing remote self-administration.

The trial enrolled 19 adults diagnosed with major depression. They began with a monitored laboratory session where they received an eight-microgram dose of liquid LSD held under the tongue, a process known as sublingual administration. Blood samples were taken to track pharmacokinetics, which is the study of how the body absorbs, distributes, and eliminates a drug from the bloodstream.

Following the initial lab visit, participants took the drug home and consumed it twice a week for eight weeks. They used a customized smartphone application to track their sleep, daily functionality, and specific mood metrics. They were allowed to slightly adjust their at-home dose between four and twenty micrograms to find their ideal personal balance.

The blood analysis revealed a distinct physiological pattern regarding drug metabolism. Individuals who naturally processed the drug faster, resulting in lower blood concentrations, tended to slowly increase their home doses. This suggests that participants were successfully adjusting their drug intake to achieve a consistent subjective effect, compensating for their unique internal biology.

The daily tracking data showed specific patterns of acute mood elevation. On the exact days they consumed the microdose, participants logged higher levels of energy, creativity, and social connection. They also reported feeling happier and less irritable on the two days immediately following the dose. Experiencing surges in creative energy might encourage depressed individuals to engage in rewarding social behaviors, creating a positive feedback loop over time.

The participants did not report the drug feeling weaker or stronger over the eight weeks. This lack of tolerance or sensitization is a notable finding, as many psychiatric drugs quickly lose their effectiveness without dosage increases. A formal clinical interview conducted at the end of the entire trial showed an average drop in depression severity of sixty percent across the group.

Exploring Population-Level Behavioral Links

The influence of psychedelics extends beyond controlled laboratory settings, affecting broad population health trends. James M. Zech, a researcher at Florida State University, analyzed federal health data to explore the link between recreational psychedelic use and alcohol addiction. The study was published in the Journal of Psychoactive Drugs.

Alcohol use disorder is a pervasive public health challenge marked by an inability to control drinking despite the resulting physical and social harm. Seeking alternative treatments, researchers have recently focused on substances like psilocybin and MDMA. Zech and his colleagues wanted to see if the therapeutic signals found in clinical trials also appeared among recreational users in the general public.

The team pooled survey data from nearly 140,000 American adults collected between 2021 and 2023. They adjusted their statistical models to account for factors like age, income, education level, and the use of other substances like tobacco and cannabis. The researchers then looked for connections between past-year drug use and a formal diagnosis of alcohol use disorder.

The analysis revealed that adults who used LSD in the past year were significantly less likely to meet the criteria for alcohol use disorder. The adjusted data indicated a 30 percent reduction in likelihood compared to non-users. Among individuals who did have the disorder, recent users reported approximately 15 percent fewer symptoms overall.

Other popular substances, such as ketamine and MDMA, did not show a similar statistical association with alcohol problems over the same twelve-month period. The authors suggest that the psychological shifts often reported by LSD users, such as increased openness and decreased neuroticism, might reduce the underlying mental drivers of heavy drinking.

Uncovering Unexpected Neuroprotective Properties

In a surprising departure from psychiatric research, scientists have also identified potential neuroprotective benefits of psychedelics. A team at the University of Toronto tested LSD in a mouse model of severe seizures. The research produced two related papers published in Next Research and Brain Research.

The project began strictly as a safety test. Some patients experience both epileptic seizures and functional seizures, which are psychological events that mimic epilepsy without the abnormal electrical discharges. Before proposing psychedelics as a psychological treatment for functional seizures, the researchers needed to verify the drug would not worsen actual epilepsy.

“This work started in a completely different direction than it ended up going in,” study author Brenden Rabinovitch told PsyPost. The researchers administered either a saline solution or an active dose of the drug to adolescent mice. They then injected the animals with kainic acid, a chemical that overstimulates neurons and reliably induces severe seizures.

The behavioral outcomes were highly unexpected. In the control group, nearly 40 percent of the male mice entered a life-threatening state of continuous seizures, known as status epilepticus, and many died. In stark contrast, male mice treated with the higher dose of LSD showed a complete absence of this dangerous state, and none died. The drug appeared to halt the progression of the most severe convulsions.

The behavioral responses among the mice were completely unanticipated. “When we saw that certain behavioural characteristics of seizures actually improved in these mice, we were shocked to say the least,” Rabinovitch previously told PsyPost.

To uncover the hidden biological mechanism, the team implanted electrodes into the brains of freely moving mice. They found that the drug caused a broad reduction in the power and amplitude of electrical brain waves. The recorded brain signals became less predictable and more chaotic, heavily aligning with the entropic brain theory.

Because epileptic seizures rely on hypersynchronized, rigid patterns of electrical firing, this drug-induced chaos may act as a neuroprotective barrier. By lowering the power of neural rhythms, the substance makes it difficult for hypersynchronized seizure activity to organize and spread across the brain. The drug essentially introduces enough noise into the system to prevent the seizure from generalizing.

Engineering a Hallucination-Free Alternative

Despite the therapeutic potential of classic psychedelics, their hallucinogenic effects pose significant risks for individuals with a family history of psychosis or schizophrenia. To solve this problem, scientists at the University of California, Davis engineered a new chemical analogue named JRT. The research was published in the Proceedings of the National Academy of Sciences.

Psychedelics are highly effective at promoting neuroplasticity, which is the brain’s ability to grow new connections and repair damaged circuits. This growth is essential for treating conditions characterized by the shrinking or atrophy of neurons. The research team aimed to modify the structure of LSD just enough to preserve this brain-repairing capacity while stripping away the hallucinogenic experience.

“One of the hallmarks of schizophrenia is atrophy of neurons in the cortex,” lead author David E. Olson told PsyPost in a 2025 interview. “We decided to engineer an analogue of LSD with lower hallucinogenic potential in the hopes that this neuroplasticity-promoting compound might be useful for treating these patients.”

The scientists achieved this goal by flipping the position of exactly two atoms in the drug’s complex molecular structure. This tiny adjustment removed a specific chemical bond that typically interacts with the serotonin 2A receptor to produce hallucinations. The new compound, named after the graduate student who designed it, had to be synthesized entirely from scratch in the laboratory.

Laboratory tests using rat brain cells showed that JRT promoted substantial growth in dendritic branches, exceeding even the performance of the original drug. In live mice, a single dose increased synapse density in the prefrontal cortex and reversed brain damage induced by chronic stress. This provides evidence that the new analogue maintains the profound neuroplasticity benefits of its parent compound.

Importantly, JRT did not trigger head-twitch behaviors in mice, a standard biological marker used by scientists to predict hallucinogenic activity. It also produced antidepressant-like outcomes and improved cognitive flexibility in stressed animals. The drug showed high selectivity for serotonin receptors, completely avoiding other receptor types that often cause weight gain and sedation in standard psychiatric medications.

“I was surprised that transposing only two atoms was sufficient to drastically change the pharmacology of LSD,” Olson previously told PsyPost. “Even small chemical alterations to the structures of psychedelics have the potential to profoundly improve their safety and efficacy profiles.”

Limitations and Future Directions

Evaluating these scientific advancements requires close attention to study design and inherent limitations. Several of the brain imaging experiments and microdosing trials relied on very small groups of participants. Expanding these participant pools in future studies is necessary to ensure the observed physiological changes reliably apply to the broader adult population. The demographics in many of these trials were also highly restricted, and future projects must include more diverse groups to validate the findings.

Participant expectations exert a massive influence on psychiatric research, especially in open-label trials where volunteers know they are receiving a famous psychedelic compound. This awareness can easily trigger a placebo effect, where patients report better moods simply because they anticipate a positive outcome. Proving true clinical efficacy requires randomized, double-blind trials that compare active drug groups against inactive placebo groups to isolate actual chemical benefits.

Translating animal research into human treatments presents another layer of scientific complexity. The seizure protection and non-hallucinogenic brain repair experiments were conducted in rodents, and human brain physiology is vastly more intricate. Subjective human experiences often differ from behavioral markers seen in mice, meaning extensive clinical trials will be needed to verify safety and effectiveness in clinical environments.

Looking forward, medical researchers plan to track patients over much longer periods to determine if repeated dosing builds tolerance or sustains long-term healing. Scientists are also focused on exploring how new chemical analogues might rescue damaged brain tissue in debilitating neurodegenerative conditions. As researchers map the precise timing of neural changes, they hope to develop targeted interventions that harness the brain-altering power of psychedelics safely and predictably.

The study, “Knocking at the Doors of Perception: Relating LSD Effects on Low-Frequency Fluctuations and Regional Homogeneity to Receptor Densities in fMRI,” was authored by Paolo La-Torraca-Vittori, Livio Tarchi, Elisa Arrigo, Stefano Lanterna, Eleonora Tosi, Arne Doose, Fulvia Palesi, Doris Pischedda, Valdo Ricca, Paolo Fusar-Poli, and Stefano Damiani.

The study, “Lysergic acid diethylamide-derived excitatory/inhibitory ratio change enhances global synchrony in functional brain dynamics,” was authored by Lingyu Zhang, Weiyang Shi, Ziyang Zhao, Zhichao Wang, Congying Chu, Bokai Zhao, Jiaqi Zhang, Qianhui Liu, Yueheng Lan, and Tianzi Jiang.

The study, “LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial,” was authored by Dimitri Daldegan-Bueno, Carina Joy Donegan, Rachael Sumner, Anna Forsyth, Soo Hee Jeong, William Evans, Malak Alshakhouri, Robin J. Murphy, Lisa Reynolds, Nicholas Hoeh, Nathan Allen, Frederick Sundram, David B. Menkes, and Suresh Muthukumaraswamy.

The study, “Reward-related neural activity after low doses of LSD in participants with depressed mood,” was authored by James Glazer, Hanna Molla, Royce Lee, Robin Nusslock, and Harriet de Wit.

The study, “Lysergic acid diethylamide inhibits status epilepticus and mortality in a mouse model of acute kainic acid-induced motor seizures,” was authored by BS Rabinovitch, W Hu, C Tang, N Silverman, EC Lewis, and PL Carlen.

Chapter 1000: Nature Communications

A study has found one single dose of magic mushrooms can transform the brain physically — with changes lasting as long as a month.

The study, published in Nature Communications, aimed to identify the exact changes the brain undergoes after being exposed to psilocybin — the psychedelic substance in magic mushrooms.

Researchers hoped their findings would support calls for the drug to be used in therapeutic settings to treat anxiety, depression and addiction.

Initially, the 28 participants — who had no history of mental illness — were given a placebo and monitored for a month.

During that month, scientists measured psychological insight, well-being and cognitive performance, while using fMRI imaging to observe connections in the brain.

In the second stage of the experiment, the participants were given 25 mg of psilocybin — enough for a psychedelic experience, or “trip.”

Their brains were monitored during the trip and for the weeks after.

Within an hour of taking the dose, researchers observed a rise in brain entropy — the term used to describe intense neural activity, characterized as complex, unpredictable and flexible.

This means the brain was capable of understanding and processing more information than usual. And that wasn’t just in the short term.

One month after the trip, the participants’ brains showed denser neural tracts with greater integrity — the opposite of what can be observed in an aging brain.

The ability to break thought patterns is why researchers believe it has a place in a therapeutic setting.

Participants were also asked to respond to statements like “I’ve been feeling optimistic about the future” and “I’ve been dealing with problems well,” to determine their mental state two and four weeks after the dose.

Researchers noted a marked improvement in this responses at both the second and fourth week after the trip.

They were also asked to take part in a cognitive flexibility test before and after the dose — which measures the ability to adapt thinking and respond to changing information.

All participants performed better on the test after taking magic mushrooms.

The researchers also found that those who experienced the greatest increase in brain entropy — and therefore those who most likely had the most intense “trip” — showed a greater improvement in well-being and cognitive ability.

“We already knew psilocybin could be helpful for treating mental illness. But now we have a much better understanding of how,” said senior author Robin Carhart-Harris.

Chapter 800: Ayahuasca, Mushrooms, LSD: Businessman’s Spirituality?

https://www.psychologytoday.com/us/blog/the-pleasure-is-all-yours/202208/could-the-biggest-game-changer-in-mental-health-be-plant?fbclid=IwAR3g0Mph5x93D1PDXaoXytSKra57TQhJ2tB1McDKLlt_zewTanXen87iFkA

In the early 1970’s, I used LSD (lysergic acid diethylamide) close to twenty times. The trip would last up to 12 hours.

I was also introduced to DMT, which was called “the businessman’s LSD” because it only lasted about 2-3 hours, and who has time for an all day adventure?

Nature is a true healer. Mankind’s separation from Nature is what creates many diseases, forms of mental illness, wayward religions (religions are for people too lazy, or too busy, to fulfill their spiritual commitment) and Capitalism. As has been said, be careful when you follow the masses, for often the “m” is silent. When many are hypnotized by the same delusion, it is called “religion”, or, of course, capitalism.

LSD worked wonders for me in high school, and college, but I had no intention to permanently erase the ego. Those who used lsd too frequently damaged their own mental health, so there is a limit to suspending the ego chemically.

The ego is not the enemy, ignorance, self delusion, and stupidity is. Intelligence formed from listening to the silence within, and having that insight inform our knowledge and memories will bring salvation to our planet, and to our self. Negating the value of the ego will not accomplish anything, save put you in the same category of those who practice ” spiritual bypass”.

If you need psychedelics, natural or man made, to get there, so be it.
Ram Dass would certainly approve.

Me?

I am not a businessman. I took the long path to my own salvation. I know that we each are responsible for our “salvation”, not some savior, or drug. We each need to work long, and hard, to achieve our spiritual goals. No one will do this work for us.
Work with integrity upon your traumas.
Work with integrity upon your spiritual path.

If you can’t find the sacred silence without Nature’s help, then, by all means, take advantage of her magic.

But beware of the consequences of bringing a highly chaotic mindset to this process. I highly recommend that you have first experienced a measure of healing first. You may not find what you are looking for, except more chaos, otherwise.

Psychedelic Use In An Awakened Dream

Psychedelics, Healing Potential, and Religious/Spiritual Experience

I never saw the use of LSD or psychedelics as dangerous or self-destructive, but instead as a delightful and eye-opening vacation from all of the dark certainties and crystallized structures of thought that characterized my troubled life. It all depends on the state of the mind, and our intentions, to determine if the use of mind altering chemicals whether is to be considered drug abuse or part of a evolved healing modality.

In the last two years, there has been several articles posted in Psychology Today, and in other scientific, spiritual and healing newsletters, about the possibility of some forms of psychedelics being useful in the treatment of depression and other mood disorders, as well as being an incredible aid to dying patients who may be facing the fear of death. I won’t necessarily be directly addressing those articles here, but modern research may be confirming what has already been witnessed by many users of these mind altering substances over the last fifty years. Psychedelics, and their use, could take a whole volume, if I were to describe and define all of my experiences with them over the period 1972-1980. I used LSD and mescaline during my high school years over twenty times, from early 1972 through the summer of 1973. In college, I did not use them hardly at all, nor did I use them much after that, perhaps using them once or twice a year until 1980, when I ceased using them altogether.

Psychedelia comes under a different class of psychotropic experience than alcohol, pot, amphetamines, narcotics, or downers. They were referred to as “mind expanding drugs” during the period of time when they were most popular, which began in the 1960’s and extending through the 1970’s period of time. I found psychedelics to be extremely challenging to use, yet they brought into my awareness some amazing and logic-defying experiences. I would even say that I even had exotic, supra-normal type of personal events, on several occasions.

My first time that I used LSD, I was a sophomore in high school. I had no desire to ever use the drug, as I was afraid of the potential effects on me. But, Pam’s friend, Terry Potter, gave me a small pill that had been saturated with LSD liquid to give to Pam. Pam, at this point of her life had no desire for the drug, so she gave it back to me and told me to return it to Terry. Well, I kept it, and then decided to try an ever so small amount of it, in case I had a dangerous reaction to it. I grabbed a razor blade, and scraped about one-fourth off of the pill, and ingested it, and then took a bus to downtown Portland, to hang out at the city library. Well, an amazing feeling overtook me about one hour later. I became euphoric, and I had never felt so good in my life! I felt peace, and love for everybody and everything, and being only fifteen years old and having never experienced such an energy before, I thought that I had found the “promised land”. There were no visual or auditory hallucinations, because the dose was so low, and that was just fine with me. It took longer than usual to sleep that night, as my mind remained on “high alert” well into the early morning hours. There was no hangover, nor did I regret taking the risk using the drug.

Another time, while still a sophomore in high school, I attended a concert at Washington Park, where a man sold me something called DMT, which he called the businessman’s LSD, because its effects only lasted 2-3 hours, versus the 10-13 hours LSD’s effects may cause. This drug is similar to the drug Ecstasy as it is now being sold in the US. I became euphoric on this drug, and I had a fascinating experience. Every person that I would encounter for the next two hours, I felt an incredible kinship with. I also felt as if I could understand them at some level way beyond my normal capacity. It was as if I was able to feel all of their good thoughts, so to speak. So, it was an experience of the elimination of fear for me when dealing with strangers, and giving me the sense of being connected with everybody at a level impossible to achieve while in normal states. A more sedate and sane variation of this experience was to come to me more “naturally” fifteen years later, after recovery from drug addiction and alcoholism.

While a senior in high school I had another LSD experience worth commenting upon. Marc Anderson, Mike Kelsey and myself had taken LSD together. Mike had already dropped out of high school, and had his own “rat castle” so we enjoyed LSD’s effects at Mike’s place, out of public view. One amazing effect was that somehow Marc and I became entrained, so that we would “see” the same hallucinations at the same time. Yes, I was taking the drug in high enough doses that hallucinations were now quite prominent. One of the biggest prolonged laughs that we all had together was when Mike turned into the Devil himself, with red horns, a tail, and a red face. Of course, Mike could not see it, but Marc and I saw him transform Exactly at the same time, and we could not stop laughing for ten minutes!!

One final experience that seems to have significance is one time I had secured a variation of LSD called Orange Sunshine, while attending a summer concert at Delta Park in north Portland. The pill itself was a small phosphorescent orange color, and boy did it pack a wallop! Any kind of visual image or scene had the likelihood of changing into almost anything else, seemingly spontaneously. When I say that the “walls were melting” at times, if I was in a room, the walls did melt with the most wonderful blending of color and sounds together. My psychological set was eliminated as well (meaning all of my personality was no longer accessible, so I was witnessing and experiencing the moment without my normal ways of experiencing reality through my conditioning). It was incredible, disorienting, wild, and transformative while under LSD’s influence. I was to have a drug induced “awakening” where I realized that I was the one controlling my very reality, and through the focus of my will and my heart I could change what I was witnessing in the world. This took on rather bizarre manifestations, with colors swirling through new images, sometimes appearing as if some sort of internal kaleidoscope were projecting images out into my visual field, ALL UNDER MY CONTROL.

When I saw how I could also experience people in a thousand different ways, depending on the position of my internal “kaleidoscope”, I came to realize that I had a lot more say in how I experienced my fellow-man than I ever realized. I can understand why Richard Alpert (Ram Dass), Timothy Leary and so many other pioneers in the modern-day exploration of human consciousness have used LSD. LSD, under the right conditions, can reveal the awesome powers, and potential, of the unconditioned human mind. It can be temporarily transformational, and potentially quite beautiful, and dangerous, as well.

I found that the older that I got, the less of a positive experience that I had with psychedelics so I stopped all use. In 1980, I used LSD for the last time, sharing the experience with Dan Dietz. I had trouble “coming down” from the experience, and it took two days to return to my normal “psychological set”. That second day, I feared that I would never return to normal, and that I would be stuck for the rest of my life in this in-between state of anxiety and mental illness. I was never tempted to use LSD again.

While there is a huge potential upside to the use of psychedelics, there can also be downside to their use, and the person contemplating mind altering drugs should research this subject, as if for an upper graduate degree. There are Ayahuasca excursions into the Amazon jungle, where the local shamans administer a concoction to the participants seeking a deeper understanding of their own life, and their spirit connection with the absolute.. There are terminal ill patients therapeutically using psychedelics, which has been shown to reduce or eliminate “death terrors” for such patients, while also providing profound guidance for those terminally ill persons. Those seeking such experiences can find appropriate therapists who have access to these drugs and are willing to administer them to the appropriate patient, but they obviously don’t advertise these capabilities on their web sites.

I do not regret ever having used a psychedelic drug. If there was a logical reason for using them again, I would consider that as a viable option. Ram Dass has many great stories around his use of psychedelics, and it is not my intention to become a cheerleader for those who continue to use them, or to become a proponent for the human experimentation of these mind altering substances, and their potential application for improving mental health and spiritual awareness.

Psychedelics worked for me, but only for a short period of time. For now, I am quite satisfied with my connection to the “higher power” that I have developed through the practice of meditation and mindfulness, exercise, healthy food, and social connections. The positive aspects of mind expansion without drugs occurred for me much later in adulthood, and I had similar sorts of mind altering experiences, in much more natural, permanent, and less disruptive ways.

Chapter 700: Psychedelic Assisted Recovery From Trauma And Alcoholism

Deepak Chopra, the ever popular spiritual teacher, is also a strong proponent of this mind opening intervention. So are many famous therapists and healers, including Gabor Mate, Dick Schwarz, and others.

Inquiring minds want to know what are their best options for healing from trauma/ptsd, brain health, and continuous growth. The controlled, therapeutic use of psychedelics has fascinating possibilities to assist in our journey towards the truth of our existence. Indigenous peoples have used such plant medicine for thousands of years.

I am planning on attending PIR (psychedelics in recovery) meetings at the Alano Club, Portland. I attended my first AA meeting there in 1980. I literally attended a thousand meetings there in the late 1980’s, and early 1990’s. I have extensive experience and training in recovery issues. I have had a few relapses over the intervening years between 1980 and now, with the dangerous ones in the 1980’s when I was unconscious.

I have finally learned how to not fear my alcohol consumption, but, instead, to practice mindful drinking, when I choose to consume such beverages. I still enjoy long periods of abstinence from drinking alcohol, whenever my spirit calls for a break. One of my longest breaks was nearly 20 years. Abstinence, and now, mindful drinking, is part of a new understanding of recovery for me. But the biggest and most profound part is enhancing my spiritual connection.

I presently embrace and practice several approaches to spiritual realization, including indigenous/shamanic understanding, Christian mysticism, personal inquiry and insight coupled with 12 Step work ,and the Zen Buddhist approach to viewing reality.

Sharon and I have been studying therapeutic applications and the benefits of psychedelics for years.

Many, many suffering, dying people with death terrors, and addicts, alcoholics, and mentally ill human beings can greatly benefit from this form of therapy. Those on the path of insight, with a lifelong search for Truth are benefiting, as well.

I have no plans of using LSD again, having used it to great spiritual benefit several times in the 1970’s. I have another earlier blog post devoted to that journey in the ’70’s.

Microdosing of psilocybin remains a very real possibility for Sharon, and myself, as we move towards our own infinite unfolding as conscious beings.

We are now in contact, and have befriended, several facilitators of this mode of healing and insight.

All the healing potential in the world has zero value, unless we access it, and put it into real-life practice.

Chapter 600: The Healing Potential of Psilocybin Cubensis

In the labyrinth of the human mind, where shadows of trauma and despair often dwell, a remarkable renaissance is unfolding. Psilocybin cubensis, commonly known as magic mushrooms, is emerging as a beacon of hope in the realm of mental health and wellness. This humble fungus, long shrouded in myth and controversy, is now at the forefront of groundbreaking research, offering profound healing potential for some of the most stubborn and debilitating conditions.

Recent studies have brought to light the remarkable effects of psilocybin on mental health. The compound, found in magic mushrooms, has shown promise in treating alcohol abuse, depression, PTSD, and existential distress. These studies suggest that psilocybin doesn’t merely mask symptoms but addresses the root causes of these disorders, offering new hope where conventional therapies have often fallen short.

One of the most compelling areas of research involves psilocybin’s potential to treat alcohol abuse. A study conducted by New York University found that individuals who received psilocybin-assisted therapy showed a significant reduction in drinking behavior. The therapeutic effects were not just transient; many participants maintained abstinence or significantly reduced their alcohol intake months after the treatment. This suggests a profound reset in their relationship with alcohol, facilitated by the introspective and emotionally revealing nature of the psilocybin experience.

The specter of depression has haunted humanity for centuries, often eluding effective treatment. However, research from institutions like Johns Hopkins University and Imperial College London is painting a promising picture. Psilocybin, administered in controlled settings, has shown to produce rapid and enduring antidepressant effects. Patients report a newfound clarity and release from the oppressive weight of depression, often describing their experiences as life-changing.

For those grappling with PTSD, psilocybin offers a path to healing that traditional therapies have struggled to provide. Studies have shown that psilocybin can facilitate deep emotional processing and integration of traumatic memories, leading to substantial reductions in PTSD symptoms. This therapeutic breakthrough is particularly significant for veterans and survivors of severe trauma who have found little relief in conventional treatments.

In the face of terminal illness, the fear of death can cast a long and dark shadow. Psilocybin therapy has shown promise in alleviating this existential distress, offering patients a sense of peace and acceptance. Research conducted at UCLA and Johns Hopkins University has demonstrated that psilocybin can induce profound spiritual experiences and a sense of connectedness that helps patients come to terms with their mortality.

The healing potential of psilocybin is rooted in its unique mechanism of action on the brain. Psilocybin is a prodrug that, once ingested, converts into psilocin. Psilocin binds to serotonin receptors, particularly the 5-HT2A receptor, which plays a crucial role in mood regulation and perception.

One of the most fascinating aspects of psilocybin’s action is its impact on neuroplasticity—the brain’s ability to reorganize itself by forming new neural connections. Studies have shown that psilocybin promotes neurogenesis and enhances synaptic plasticity. This increased neuroplasticity may underlie the long-lasting therapeutic effects observed in patients, allowing the brain to rewire itself in response to new experiences and insights gained during the psilocybin experience.

Psilocybin also appears to facilitate emotional processing by reducing the activity of the default mode network (DMN). The DMN is a network of interconnected brain regions that is active during self-referential thinking and rumination. By quieting the DMN, psilocybin allows for a more fluid and less rigid experience of consciousness, enabling individuals to confront and process deeply buried emotions and traumas.

The resurgence of interest in psilocybin has prompted a reevaluation of its legal and ethical status. Historically, psilocybin and other psychedelics have been classified as Schedule I substances, deemed to have no medical use and a high potential for abuse. However, this perspective is rapidly changing.

Countries like Canada, the Netherlands, and certain U.S. states have begun to relax regulations surrounding psilocybin, allowing for its use in clinical and therapeutic settings. These regulatory changes reflect a growing recognition of psilocybin’s potential benefits and a desire to integrate it into mainstream mental health care.

As the use of psilocybin expands, ethical considerations must be addressed. Ensuring patient safety, informed consent, and equitable access to psilocybin therapy are paramount. Additionally, there is a need for culturally sensitive approaches that respect the traditional use of psilocybin by indigenous communities.

One of the unique aspects of psilocybin therapy is its integration of spiritual and psychological elements. This holistic approach, often referred to as “journeying,” emphasizes the profound personal insights and transformative potential of the psilocybin experience.

Many individuals who undergo psilocybin therapy report experiences of deep spiritual significance. These experiences often involve a sense of unity with the universe, a dissolution of the ego, and a profound understanding of one’s place in the world. Such insights can be incredibly healing, providing a sense of purpose and direction that extends beyond the therapy session.

To fully harness the benefits of psilocybin, it is essential to integrate these spiritual insights with psychological therapy. This integration process helps individuals make sense of their experiences and apply the lessons learned to their daily lives. Skilled therapists play a crucial role in guiding this integration, ensuring that the insights gained during the psilocybin experience translate into lasting positive change.

The renaissance of psilocybin cubensis in medical and wellness communities represents a paradigm shift in our understanding of mental health and healing. From treating alcohol abuse and depression to alleviating PTSD and existential distress, psilocybin offers a new frontier of therapeutic possibilities. Its unique mechanism of action on the brain, combined with its ability to facilitate profound personal and spiritual insights, challenges conventional approaches to psychiatric treatment.

As ethical and regulatory landscapes evolve, the integration of psilocybin into clinical settings offers a more comprehensive and holistic approach to mental health care. By embracing both the scientific and spiritual dimensions of psilocybin therapy, we can unlock its full potential and pave the way for a brighter, more hopeful future for those struggling with mental health challenges.

To explore the healing potential of psilocybin and join the conversation on its future, stay informed about the latest research and developments in this groundbreaking field.

The Potential Of Psychedelics For Healing And Insight

Imagine unlocking the doors of perception, peering into realms of the mind previously unexplored, and discovering new pathways to healing and self-discovery. Welcome to the world of psychedelics. Psychedelics, such as ketamine, psilocybin, LSD, MDMA, Ayahuasca, and DMT, have long fascinated humanity with their ability to induce profound experiences.

Psychedelics have a rich history dating back centuries, intertwined with various cultures and spiritual practices. Ancient civilizations, such as the Aztecs and various indigenous tribes of North, Central, and South America, incorporated psychedelics into rituals and ceremonies, considering them gateways to divine realms and sources of profound wisdom. By exploring these historical uses, insight may be gained into the enduring fascination and reverence for these substances.

There are many personal stories and case studies available that provide powerful glimpses into the transformative potential of psychedelics. These narratives highlight the deeply profound experiences that individuals have undergone, often leading to insights, emotional healing, and personal growth. While personal stories should not be considered scientific evidence, they offer valuable perspectives on the impact psychedelics have had on many lives.

In the last two years, there have been several articles posted in Psychology Today, and in other scientific, spiritual and healing newsletters, about the possibility of some forms of psychedelics being useful in the treatment of depression and other mood disorders, as well as being an incredible aid to dying patients who may be facing the fear of death. Modern research may be confirming what has already been witnessed by many users of these mind-altering substances over the years.

Psychedelia comes under a different class of psychotropic experience than alcohol, pot, amphetamines, narcotics, or downers. They were referred to as mind-expanding drugs during the period when they were most popular, which began in the 1960s and extended through the 1970s period. I found psychedelics to be extremely challenging to use, yet they brought into my awareness some amazing and logic-defying experiences. I even had exotic, supra-normal types of personal events on several occasions.

The legal status of psychedelics varies across different countries and jurisdictions. While some psychedelics remain classified as Schedule I substances, impeding research and therapeutic use, there are signs of shifting attitudes. In recent years, breakthroughs in scientific research and growing public interest have led to legislative changes, allowing for expanded research and even decriminalization in certain regions.

In the early 1970s, I used LSD (lysergic acid diethylamide) close to twenty times. The trip would last up to 12 hours. I was also introduced to DMT, which was called “the businessman’s LSD” because it only lasted about 2-3 hours (who has the time for an all-day adventure?). I also used peyote once, and mushrooms on several occasions, but I had no extraordinary experiences with their use. On the other hand, LSD worked its magic for me in the 1970s, but I had no intention through its use to permanently erase the ego. Many who used LSD too frequently damaged their mental health, so there is a limit to suspending the ego chemically.

If you need psychedelics, natural or man-made, to get where you want to go spiritually, emotionally and/or physically, proceed with care.

Ram Dass would certainly approve.

Me?

I am not a businessman. I took the long path to my salvation. I know that we each are responsible for our spiritual salvation, not an ancient prophet or savior, or any new wonder drug. My experience tells me that we each need to work long, and hard, to achieve our spiritual goals. No one will do this work for us. Our ego is not the enemy, as ignorance, self-delusion, and stupidity are the real culprits. Intelligence formed from listening to the silence within and having that insight inform our knowledge and memories will bring salvation to our planet, and to ourselves. Negating the value of the ego rather than fine-tuning it will not accomplish anything significant, other than further damaging one’s sense of self-esteem.

Work with integrity upon your traumas.

Work with integrity upon your spiritual path.

If you can’t find the sacred silence without Nature’s help, then, by all means, take advantage of her magic.

But beware of the consequences of bringing a highly chaotic mindset to this process. I recommend that you first have experienced a measure of healing. Otherwise, you may not find what you are looking for, except more chaos..

I never saw the use of LSD or psychedelics as dangerous or self-destructive, but instead as a delightful and eye-opening vacation from all of the dark certainties and crystallized structures of thought that characterized my troubled early life. It all depends on the state of the mind, and our intentions, to determine if the use of mind-altering chemicals is to be considered drug abuse or part of an evolutionary healing consciousness.

Psychedelics, and their use, could take a whole volume if I were to describe and define all of my experiences with them over the period 1972-1980. I used LSD and mescaline during my high school years over twenty times, from early 1972 through the summer of 1973. In college, I did not use them hardly at all, nor did I use them much after that, perhaps using them once or twice a year until 1980, when I ceased their usage..

The first time that I used LSD I was a sophomore in high school. I had no desire to ever use the drug as I was afraid of the potential effects on me. But, my sister Pam’s friend, Terry P., gave me a small pill that had been saturated with LSD liquid to give to her. Pam, at this point in her life, had no desire for the drug, so she gave it back to me and told me to return it to Terry. I kept it and then decided to try an ever-so-small amount of it, in case I had a dangerous reaction to it. I grabbed a razor blade, and scraped about one-fourth off of the pill, and ingested it, and then took a bus to downtown Portland, to hang out at the city library. An amazing feeling overtook me about one hour later. I became euphoric, and I had never felt so good in my life! I felt peace, and love for everybody and everything, and being only fifteen years old and having never experienced such an energy before, I thought that I had found the promised land. There were no visual or auditory hallucinations, because the dose was so low, and that was just fine with me. It took longer than usual to sleep that night, as my mind remained on high alert well into the early morning hours. There was no hangover nor did I regret taking the risk of using the drug.

Another time, while still a sophomore in high school, I attended a concert at Washington Park, where a man sold me something called DMT, which he called the businessman’s LSD because its effects only lasted 2-3 hours, versus the 10-13 hours LSD’s effects may cause. I became euphoric on this drug, and I had a fascinating experience. Every person that I would encounter for the next two hours, I felt an incredible kinship with. I also felt as if I could understand them at some level way beyond my normal capacity. It was as if I was able to feel all of their good thoughts, so to speak. So, it was an experience of the elimination of fear for me when dealing with strangers, and it gave me the sense of being connected with everybody at a level impossible to achieve while in a normal state. A more sedate and sane variation of this experience was to come to me more naturally fifteen years later, after recovery from drug addiction and alcohol abuse .

While a senior in high school I had another LSD experience worth commenting upon, when Marc A., Mike K. and I took LSD together. Mike had already dropped out of high school, and had his own “rat castle” so we enjoyed LSD’s effects at Mike’s place, out of public view. One amazing effect was that somehow Marc and I became entrained so that we would see the same hallucinations at the same time. I was now taking the drug in high enough doses that hallucinations were quite prominent. One of the biggest prolonged laughs that we all had together was when Mike turned into the Devil himself, with red horns, a tail, and a red face. Of course, Mike could not see it, but Marc and I saw him transform Exactly at the same time, and we could not stop laughing for ten minutes!!

One final experience that seems to have significance is one time I had secured a variation of LSD called Orange Sunshine while attending a summer concert at Delta Park in north Portland. The pill itself was a small phosphorescent orange color, and boy did it pack a wallop! Any kind of visual image or scene had the likelihood of changing into almost anything else, seemingly spontaneously. When I say that the walls were melting at times, if I was in a room, the walls did melt with the most wonderful synesthesia of blending colors and sounds. My psychological set was eliminated as well, meaning all of my personality was no longer accessible, so I was witnessing and experiencing the moment without my normal ways of experiencing reality through my conditioning. It was an incredible, disorienting, wild, and transformative experience while under LSD’s influence. I was to have a drug-induced awakening where I realized that I was the one controlling my very reality, and through the focus of my will and my heart, I could change what I was witnessing in the world. This took on rather bizarre manifestations, with colors swirling through new images, sometimes appearing as if some sort of internal kaleidoscope were projecting images out into my visual field, ALL UNDER MY CONTROL.

When I saw how I could also experience people in a thousand different ways, depending on the position of my internal kaleidoscope, I came to realize that I had a lot more say in how I experienced my fellow man than I ever realized. I can understand why Richard Alpert (Ram Dass), Timothy Leary, Bill Wilson, and so many other pioneers in the modern-day exploration of human consciousness have used LSD. LSD, under the right conditions, can reveal the awesome powers and potential of the unconditioned human mind. It can be temporarily transformational and quite beautiful, and, potentially, dangerous, as well.

I found that the older I got, the less of a positive experience that I had with psychedelics so I stopped all use. In 1980, I used LSD for the last time, sharing the experience with Dan Dietz. I had trouble coming down from the experience, and it took two days to return to my normal psychological set. That second day, I feared that I would never return to normal and that I would be stuck for the rest of my life in this in-between state of anxiety and mental illness. I was never tempted to use LSD again.

While there is a huge potential upside to the use of psychedelics, there can also be a downside to their use, and the person contemplating mind-altering drugs should research this subject, as if for an upper graduate degree. There are Ayahuasca excursions into the Amazon jungle, and now, local retreats, where shamans administer a concoction to the participants seeking a deeper understanding of their own life, and their spiritual connection with the absolute. Many, many suffering, dying people with death terrors, and addicts, alcoholics, and mentally ill human beings can greatly benefit from this form of therapy.

There are terminally ill patients therapeutically using psychedelics, which has been shown to reduce or eliminate “death terrors” for such patients, while also providing profound guidance for those terminally ill persons. Those seeking such experiences can find appropriate therapists who have access to these drugs and are willing to administer them to the appropriate patient, but they don’t advertise these capabilities on their websites.

I do not regret ever having used a psychedelic drug. As there are logical reasons for using them again, I am now considering them as viable therapeutic options. There are many great stories now available about the use of psychedelics in therapeutic and quasi-therapeutic settings.. It is not my intention to become just another cheerleader for those who want to use or continue to use them. Yet, through writings such as this I may become perceived as a proponent for the human experimentation of these mind-altering substances and their potential application for improving mental health and spiritual awareness.

So be it.

Psychedelics worked for me with the intentions, or lack of them, that I entertained for their use in the 1970s. The positive aspects of mind expansion without drugs have occurred for me in adulthood, and I value all such mind-altering and expanding experiences that have led to enhanced insight, wisdom, and healing for me. From 1987 through 2022, I was satisfied with my connection to the higher power that I had developed through the practice of meditation and mindfulness, exercise, healthy food, and social connections.

Bill Wilson of AA renown, 20 years after his own recovery from alcoholism in 1935, engaged in psychedelic therapy for his chronic depression, beginning in 1955. He believed that this therapy would be of great benefit to those recovering people who could not find, or experience, God (or Cosmic Energy, Spirit, Higher Power, etc). Deepak Chopra, the ever popular spiritual teacher, is also a strong proponent of this mind opening intervention. Gabor Mate, Dick Schwarz, and other internationally known healers are firmly in support of this form of healing.

I attended my first PIR (psychedelics in recovery) meetings at the Alano Club, Portland on Thursday, October 12th, 2023. I also attended my first AA meeting in that same recovery house in 1981. I have attended nearly a thousand meetings there from 1984 through the early 1990’s. I have extensive experience and training in recovery issues. I have had a few relapses over the intervening years between 1980 and now, with the most dangerous ones in the 1980s while I was still unconscious. I have finally learned how to not fear alcohol consumption, but, instead, to practice mindful drinking, when I choose to consume such beverages. I still enjoy long periods of abstinence from drinking alcohol, whenever my spirit calls for a break. One of my longest breaks was 19 years, which ended when I had a malignant melanoma diagnosis in 2005. This led to a period in my life where I abused oxycontin to the point of needing two years of therapy to heal from that humbling experience.

Abstinence from intoxicating, mind numbing drugs and practicing mindful drinking is part of a new understanding of recovery for me. But the biggest and most profound part of recovery is enhancing my spiritual connection, and embracing an indigenous/shamanic, Christian mystical, personal inquiry and insight practice coupled with continued 12 Step work ,and a Zen Buddhist approach to viewing reality. This conscious work began in 1971 when I first practiced meditation, and 1972 when I first listened to Alan Watts, the Zen Buddhist master. Watts’ death in 1973, and drug addiction and alcohol abuse took me away from all practices when I entered college.

My usage of LSD in the early 1970’s revealed to me a vast, creative beauty embodied within the unexplored regions of my consciousness. But, at those late teenage years when I first used LSD, I did not have sufficient spiritual/emotional maturity with its enhanced context to support continued expanding consciousness.

Sharon and I have been studying therapeutic applications and the benefits of psychedelics for years. Microdosing of psilocybin began for my wife and I late in 2022. I had my first journey with a facilitator in October of 2022, with dramatic and healing insights gained into the wounds that early trauma, and then culturally acquired trauma, left upon my heart/soul. This has allowed me to explore new paths of healing from an auto-immune disorder that has recently plagued me. I am not rejecting Western Medicine, yet using expensive medications with side-effects for the rest of my life is an unappealing option. If I can reach in consciousness the source of my dysfunction, I may be able to remove the factor(s) that encourage the continuance of my auto-immune disorder.

We continue to move in greater circles of understanding and towards our own infinite unfolding as conscious beings. Inquiring minds such as our own want to know what are the best options for healing from trauma/ptsd, enhanced brain health, and continuous spiritual growth, while receiving positive social support, rather than negative judgments from others. We are now in contact, and have befriended, several facilitators of this mode of healing and insight. All the healing potential in the world has zero value, unless we access it, and put it into real-life practice.

While psychedelics show promise for mental health and personal growth, it is essential to be aware of potential risks and safety considerations. Psychedelic experiences can be intense and emotionally challenging, requiring careful preparation, adequate support, and a suitable environment. Risks include adverse psychological reactions, potential exacerbation of pre-existing conditions, and interactions with certain medications. It is crucial to approach psychedelics with respect, informed guidance, and a thorough understanding of individual factors and contraindications.

The potential of psychedelics for healing and insight is a compelling field of research and exploration. From their historical use in ancient cultures to the current resurgence of interest in therapeutic applications, psychedelics offer a unique lens into the human mind and its capacity for growth and transformation. As research continues to unfold and legal barriers evolve, it is an exciting time for individuals, mental health professionals, and researchers alike to explore the potential benefits of these substances.

Nature is a true healer. Mankind’s separation from Nature, and disrespect and disregard for its human/animal body is what creates many diseases, forms of mental illness, wayward politics and religions and Capitalism. Be careful when you follow the masses, for often the “m” is silent. When many are hypnotized by the same delusion, it is called mass hypnosis, which includes many religions, and, of course, Capitalism.

My advise to all is use extra caution when the latest trends, or even resurgence of ancient ones, captivate the attention of the general public, including within politics, religion, spirituality and psychedelic use.

Psychedelics and the Human Mind: A Pathway to Healing and Insight

Psychedelics have long fascinated humanity, from ancient cultural rituals to the cutting-edge research of today. These substances have the potential to unlock profound healing and insight, but with great power comes great responsibility. The resurgence of interest in psychedelics for therapeutic applications is not just a trend; it’s a paradigm shift in how we understand and approach mental health, personal growth, and consciousness.

One of the most critical aspects of a psychedelic experience is the concept of “set and setting.” First coined by Timothy Leary in the 1960s, these terms refer to the mindset (“set”) and the physical and social environment (“setting”) in which the psychedelic experience occurs. Historical contexts, such as the use of Ayahuasca in Amazonian tribes, highlight the significance of rituals and community in optimizing these experiences. Modern research supports this, showing that a favorable set and setting can significantly enhance the benefits and minimize the risks of psychedelics.

Mindset Preparation: Engage in practices like meditation, journaling, and setting clear intentions before your experience.
Controlled Environment: Choose a safe, comfortable space, preferably with someone you trust who can provide support.
Positive Social Setting: Surround yourself with supportive, like-minded individuals who understand and respect the process.

While the psychedelic experience itself can be transformative, the real work begins afterward through integration. Integration involves reflecting on the insights gained during the experience and applying them to your daily life. This process is crucial for maximizing the long-term benefits and ensuring that the experience leads to meaningful growth.

Practical Steps for Post-Experience Reflection and Growth

Journaling: Write down your thoughts and feelings about the experience.
Therapy Sessions: Work with a therapist who specializes in psychedelic integration.
Community Support: Join groups or forums where you can share your experiences and learn from others.

Psychedelics are not a one-size-fits-all solution. Individual factors such as medical history, psychological state, and current medications must be considered to ensure a safe and beneficial experience. Thorough medical and psychological assessments are essential to tailor the approach to each individual, minimizing risks and maximizing benefits.

Essential Personalized Approaches

Medical Assessments: Consult healthcare providers to evaluate any potential contraindications.
Psychological Screenings: Ensure you’re in a stable mental state, free from untreated mental health conditions.
Informed Guidance: Seek advice from professionals experienced in psychedelic therapy.

Emerging research highlights the potential of psychedelic therapy in treating mental health conditions such as depression, anxiety, and PTSD. Substances like psilocybin, MDMA, and LSD are showing promise in clinical trials, offering new hope for those who haven’t responded to traditional treatments. However, professional guidance and a controlled environment are crucial for these therapies to be effective and safe.

Promising Research Areas

Depression: Studies indicate that psilocybin can help alleviate treatment-resistant depression.
Anxiety: MDMA-assisted therapy shows promise in reducing symptoms of anxiety, especially in patients with life-threatening illnesses.
PTSD: Early trials suggest that MDMA can significantly reduce PTSD symptoms, even in chronic, treatment-resistant cases.

The field of psychedelic research and therapy is not without its ethical considerations and challenges. Issues such as informed consent, accessibility, and the potential for misuse must be carefully navigated. A balanced view recognizes both the promises and pitfalls, advocating for responsible use and equitable access.

Key Ethical Considerations

Informed Consent: Ensure participants fully understand the potential risks and benefits.
Accessibility: Advocate for equitable access to psychedelic therapies, regardless of socioeconomic status.
Regulation: Support policies that promote safe and controlled use while preventing misuse.

As the landscape of psychedelic research continues to evolve, future directions should focus on promoting safe, informed, and equitable access. This includes advocating for policy changes that facilitate research, ensuring rigorous studies that validate the efficacy and safety of these treatments, and creating educational resources for both professionals and the public.

Proposed Future Directions

Policy Advocacy: Support legislation that allows for expanded research and controlled therapeutic use.
Rigorous Research: Fund and conduct studies to further understand the long-term effects and potential applications.
Educational Resources: Develop training programs for mental health professionals to safely incorporate psychedelics into their practice.

For those interested in taking the next step, consider consulting with professionals who specialize in psychedelic therapy and integration. By approaching psychedelics with respect, informed guidance, and a thorough understanding of individual factors and contraindications, we can unlock their full potential for healing and growth.

Navigating an Unassisted Psychedelic Journey for Health and Wellness

Psychedelics have captured the interest of many seeking mental clarity and personal growth. One intriguing application is using these substances to foster a healthier relationship with yourself, and your use of alcohol, sugar, and inflammatory foods. If you’re ready to take an unassisted psychedelic journey with these, or any other, goals in mind, this article will guide you through the process of preparation, self-monitoring during the experience, and ensuring a safe and supportive environment.

The foundation of any successful psychedelic experience lies in setting clear intentions. This is especially crucial when your goals are health-related. Here’s why:

Mental Reset: Psychedelics can offer a profound mental reset, breaking addictive patterns and opening pathways to healthier behaviors.
Focused Goals: By defining your intentions, such as reducing your intake of alcohol, sugar, and inflammatory foods, you create a roadmap for your journey.

Practical Steps to Set Intentions:

Reflect on Your Goals: Spend time contemplating what you hope to achieve. Write down your specific health goals.
Visualize Success: Picture yourself achieving these goals. What does it feel like to have a healthier relationship with food and drink?
Affirmations: Develop a set of positive affirmations to reinforce your intentions. Repeat these daily leading up to your experience.

Preparing for Your Journey

Preparation is key to maximizing the benefits of your psychedelic experience. A unique approach combines diet and mindfulness practices to promote mental clarity and reduce inflammation.

Personalized Diet:

Eliminate Inflammatory Foods: Avoid processed foods, refined sugars, and alcohol in the weeks prior to your experience.
Focus on Whole Foods: Incorporate plenty of fruits, vegetables, lean proteins, and healthy fats.
Hydration: Drink plenty of water to keep your body hydrated and functioning optimally.

Mindfulness Practices:

Meditation: Engage in daily meditation to center your mind and enhance self-awareness.
Breathing Exercises: Practice deep breathing techniques to reduce stress and anxiety.
Physical Activity: Regular exercise can help to clear your mind and prepare your body for the experience.

Self-Monitoring During the Journey

Self-monitoring is essential to navigating your psychedelic experience effectively. This involves introspection and reflective practices to track your progress and insights.

Introspection Tools:

Journaling: Keep a journal to document your thoughts, feelings, and insights during the experience. This can be invaluable for post-journey reflection.
Check-Ins: Periodically check in with yourself to assess how you’re feeling and progressing towards your intentions.

Reflective Practices:

Guided Imagery: Use guided imagery exercises to explore your intentions in a deeper context.
Mindful Observation: Pay close attention to any thoughts or emotions that arise, observing them without judgment.

Addressing Risks and Challenges

While psychedelics have great potential for personal growth, they also carry risks and challenges. Being informed and creating a supportive environment can help mitigate these risks.

Potential Risks:

Psychological Distress: The experience can sometimes be overwhelming. Be prepared to face challenging emotions.
Physical Discomfort: Some individuals may experience nausea or other physical symptoms.

Creating a Supportive Environment:

Safe Space: Ensure you’re in a comfortable and safe environment where you feel secure.
Support System: Have a trusted friend or family member available for support if needed.
Emergency Plan: Know when and how to seek professional help if the experience becomes too intense.

An unassisted psychedelic journey can be a powerful tool for fostering a healthier relationship with alcohol, sugar, and inflammatory foods. By setting clear intentions, preparing adequately, and practicing self-monitoring, you can maximize the benefits while minimizing the risks. Remember, the path to wellness is a personal one, and taking informed, intentional steps can lead to profound transformation.

Ready to take the first step? Begin your preparation today and explore the potential for a healthier, more mindful relationship with your body and mind.

Chapter 500: Navigating an Unassisted Psychedelic Journey for Health and Wellness

Psychedelics have captured the interest of many seeking mental clarity and personal growth. One intriguing application is using these substances to foster a healthier relationship with those who are troublesome to you, or the human body by being of optimal weight, and reducing cravings for alcohol, sugar, and inflammatory foods. If you’re ready to take an unassisted psychedelic journey with these goals in mind, I will guide you through the process of preparation, self-monitoring during the experience, and ensuring a safe and supportive environment.

The foundation of any successful psychedelic experience lies in setting clear intentions. This is especially crucial when your goals are spiritual in nature and health-related. Here’s why:

Mental Reset: Psychedelics can offer a profound mental reset, breaking addictive patterns and opening pathways to healthier behaviors.
Focused Goals: By defining your intentions, such as reducing your intake of alcohol, sugar, and inflammatory foods, you create a roadmap for your journey.

Practical Steps to Set Intentions:

Reflect on Your Goals: Spend time contemplating what you hope to achieve. Write down your specific health goals.
Visualize Success: Picture yourself achieving these goals. What does it feel like to have a healthier relationship with troubling relationships, food and drink?
Affirmations: Develop a set of positive affirmations to reinforce your intentions. Repeat these daily leading up to your experience.

Preparing for Your Journey

Preparation is key to maximizing the benefits of your psychedelic experience. A unique approach combines diet and mindfulness practices to promote mental clarity and reduce inflammation.

Personalized Diet:

Eliminate Inflammatory Foods: Avoid processed foods, refined sugars, and alcohol in the weeks prior to your experience.
Focus on Whole Foods: Incorporate plenty of fruits, vegetables, lean proteins, and healthy fats.
Hydration: Drink plenty of water to keep your body hydrated and functioning optimally.

Mindfulness Practices:

Meditation: Engage in daily meditation to center your mind and enhance self-awareness.
Breathing Exercises: Practice deep breathing techniques to reduce stress and anxiety.
Physical Activity: Regular exercise can help to clear your mind and prepare your body for the experience.

Self-Monitoring During the Journey

Self-monitoring is essential to navigating your psychedelic experience effectively. This involves introspection and reflective practices to track your progress and insights.

Introspection Tools:

Journaling: Keep a journal to document your thoughts, feelings, and insights during the experience. This can be invaluable for post-journey reflection.
Check-Ins: Periodically check in with yourself to assess how you’re feeling and progressing towards your intentions.

Reflective Practices:

Guided Imagery: Use guided imagery exercises to explore your intentions in a deeper context.
Mindful Observation: Pay close attention to any thoughts or emotions that arise, observing them without judgment.

Addressing Risks and Challenges

While psychedelics have great potential for personal growth, they also carry risks and challenges. Being informed and creating a supportive environment can help mitigate these risks.

Potential Risks:

Psychological Distress: The experience can sometimes be overwhelming. Be prepared to face challenging emotions.
Physical Discomfort: Some individuals may experience nausea or other physical symptoms.

Creating a Supportive Environment:

Safe Space: Ensure you’re in a comfortable and safe environment where you feel secure.
Support System: Have a trusted friend or family member available for support if needed.
Emergency Plan: Know when and how to seek professional help if the experience becomes too intense.

An unassisted psychedelic journey can be a powerful tool for fostering a healthier relationship with others, and with alcohol, sugar, and inflammatory foods. By setting clear intentions, preparing adequately, and practicing self-monitoring, you can maximize the benefits while minimizing the risks. Remember, the path to wellness is a personal one, and taking informed, intentional steps can lead to profound transformation.

Ready to take the first step? Begin your preparation today and explore the potential for a healthier, more mindful relationship with your body and mind.

The Best Diet to Reduce Arthritic Inflammation

Arthritis is a debilitating condition affecting millions worldwide. The chronic pain and mobility issues associated with it can significantly impact the quality of life. While medication and physical therapy are commonly prescribed treatments, an often-overlooked remedy lies in our kitchens—the power of a well-balanced, anti-inflammatory diet.

Diet plays a crucial role in managing arthritic conditions. Inflammation is the body’s natural response to injury or illness, but in arthritis patients, this response is often exaggerated, leading to persistent pain and tissue damage. An anti-inflammatory diet can help manage this overreaction, reducing inflammation and, subsequently, pain.

Specific dietary choices can directly impact inflammation levels in the body. Consuming foods rich in antioxidants, omega-3 fatty acids, and other anti-inflammatory compounds can help alleviate arthritis symptoms. On the other hand, diets high in processed foods, sugary drinks, and unhealthy fats can exacerbate inflammation, increasing discomfort and pain.

One of the most effective dietary approaches to reducing arthritic inflammation is the Mediterranean diet. This diet emphasizes:

Fruits and Vegetables: Rich in antioxidants that combat inflammation.
Whole Grains: High in fiber, which helps reduce inflammatory markers.
Fish: Particularly fatty fish like salmon and mackerel, which are rich in omega-3 fatty acids known for their anti-inflammatory properties.
Healthy Fats: Found in olive oil, nuts, and avocados, these fats help reduce inflammation.

Numerous studies have shown that patients adhering to the Mediterranean diet experience reduced levels of inflammatory markers and report less pain and stiffness.

Conversely, diets high in processed foods can significantly worsen arthritis symptoms. These foods are typically high in sugars and unhealthy fats, which can trigger inflammatory responses. Examples include fast food, sugary snacks, and sodas. Reducing or eliminating these from your diet can lead to noticeable improvements in inflammation and pain levels.

While the Mediterranean diet is a robust framework, it’s essential to recognize that individual responses to foods can vary. What alleviates symptoms for one person may not work for another. Therefore, it is crucial for arthritis patients to consult with healthcare professionals or nutritionists to develop personalized dietary plans tailored to their specific needs and conditions.

In conclusion, an anti-inflammatory diet is a powerful tool in managing arthritis. The Mediterranean diet, with its focus on whole foods and healthy fats, stands out as a proven method to reduce inflammation and alleviate arthritis symptoms. However, individual variation means that personalized dietary plans are essential for optimal results. By making informed dietary choices and seeking professional guidance, arthritis patients can significantly improve their quality of life and reduce their dependence on medications.

If you or someone you know is struggling with arthritis, consider exploring dietary changes as a complementary approach to traditional treatments. Your path to reduced inflammation and pain relief could start with the next meal.

Chapter 21 – Recovery, Healing, and Psychedelics

Psychedelics, Healing Potential, and Religious/Spiritual Experience

I debated whether to place this chapter in the “Damaged” section, or the “Healing and Recovery” section of this book. It all depends on the state of mind, and intentions, of the person using the chemicals whether such an experience is to be considered “drug abuse” or part of a “healing modality”. I never saw the use of LSD or psychedelics as dangerous or self-destructive, but instead as a delightful and eye-opening vacation from all of the dark certainties and crystallized structures of thought that characterized my troubled life.

Timothy Leary’s Dead, by the Moody Blues

https://www.youtube.com/watch?v=6EXCIWlm1fs

Late in 1977, when my first wife Donelle was in the middle of another relapse into schizophrenic disease, Sean, Donelle, and I undertook a road trip through much of Oregon in my 1962 Buick Skylark. We traveled through much of the Oregon Coast, into Crater Lake, where we illegally camped along the lake rim, and Eastern Oregon around the Bend area. Sean and I had our normal complement of pot and alcohol, as well as a couple of doses of powerful psychedelics, and Donelle had her mental illness, and all of the sometimes bizarre manifestations of it. Sean had known my wife almost since the beginning of my relationship with her, and he was always a kind, supportive presence for her. But, Donelle’s symptoms were hard to understand, and we were both quite helpless and felt out of control in the face of her disease of the mind. Our own disease of addictions was somehow more easily mutually understood and accepted, and we could both maintain some measure of relative emotional order, even in the face of our own insanity.

One evening, we all sat around the campfire, and Donelle continued her sometimes bizarre behavior. She was hearing some sort of collection of voices, and she would talk to herself, and sometimes confuse what we were talking about with what was going on in the secrecy of her own mind. Sean and I would cast uncomfortable facial expressions to each other, and try to engage in conversation with each other solely, especially in the moments when Donelle became overly detached and unresponsive. In a moment of insight, I spoke of my helplessness in the face of managing Donelle’s disease and treatment, and the futility of all of my attempts at understanding her mental illness.

I remembered that I had a form of LSD with me, which was not only a powerful mind expanding drug, but it was also known for occasionally creating a variety of temporary negative psychological reactions including acute paranoia, which is a form of mental illness. It was then that I wanted to take the drug, and see if it would provide any insights into Donelle’s mindset, as well as how I might manage my relationship with her mental illness. Sean thought that I should give up on that thought, and stick to the pot and alcohol. But I insisted, and I took the psychedelic. I did not receive the desired illumination, but it showed that my deepest desire was to be of help to Donelle, as well as to try to understand the nature of mental illness, and how to bring a measure of healing to a most difficult life situation.

Chapter 48: A Connection to the Infinite? – Psychedelics and Self-Discovery

Imagine for a moment that the universe operates on an unlimited bandwidth of information, energy, and consciousness. It is a hum of infinite voltage, a ceaseless transmission of life, love, and death. Yet, our human minds, by default, are tuned to a very narrow frequency—the restricted channel necessary for survival, navigating daily routines, and perceiving a linear progression of time. We operate like old radios, picking up only the strongest, most local stations, unaware of the symphonies broadcasting on the frequencies just beyond our reach. This is the station of ordinary reality.

However, deep within the human spirit resides an inexhaustible curiosity to adjust the dial, to explore the static and the harmonies that lie just beyond our standard perception. We yearn to understand the grid we are plugged into. Throughout history, certain substances have served as technologies of the soul, tools for accessing these wider frequencies. As we explore the vast collection of concepts inherent in this book, we must look at how we maintain the circuitry of the soul and the profound potential of psychedelics not as mere drugs, but as tools for calibrating our internal circuits to handle the full current of reality.

The Cosmic Circuitry and the Human Receiver

My intention here is to explore the profound potential of these substances to unlock healing, insight, and a more expansive experience of reality. Psychedelics have long fascinated humanity, from their integral role in ancient cultural rituals to the cutting-edge neuroscience of today. Substances like psilocybin, LSD, MDMA, and Ayahuasca possess the potential to unlock profound states of healing and insight, but with great power comes great responsibility. The modern resurgence of interest in their therapeutic applications is not just a fleeting trend; it represents a paradigm shift in how we understand and approach mental health, personal growth, and the very nature of consciousness.

Our culture often rewards avoidance and distraction, encouraging us to turn away from suffering or to numb it into silence. We are taught to keep the voltage low, to manage the currents of our lives within a safe, predictable range. Yet, as I discovered through painful trial and error, lasting healing demands the courage to face these inner ruins—not to wallow in the debris, but to clear space for new growth. Each insight, each honest inventory of the self, is like a chisel against the stone of our hardened defenses. When this work is undertaken together—in groups, in families, in classrooms, or spiritual communities—healing ripples outward, increasing the capacity of the entire circuit, transforming not just the individual, but the collective.

In writing this, I have often returned to the metaphor of connection. We are, in essence, biological conduits for a consciousness that far exceeds our physical containment. However, for most of my life, I was operating with a governor on my engine, a resistor in my wiring that prevented me from accessing the full spectrum of existence. One lesson I return to time and again is that true insight—the kind that rewires the system—is not merely intellectual. It is experiential. It is a product of quiet contemplation, open conversation, and mindful presence.

My own journey into these altered states began not with philosophical intent, but with the raw, untamed curiosity of youth. In the early 1970s, during my high school years, I used LSD (lysergic acid diethylamide) nearly twenty times. The first instance was almost accidental, a serendipitous glitch in my routine. I was fifteen, and my sister Pam’s friend had given me a small pill saturated with LSD to pass along to her. Pam, having no desire for it, returned it to me. Fearful yet intrigued, I scraped off a mere quarter of the pill and ingested it before heading to the downtown Portland library.

About an hour later, a feeling I had never known washed over me. It was pure euphoria—a profound sense of peace and an unconditional love for everything and everyone. At that tender age, having never experienced such a powerful current of energy, I felt I had stumbled upon the promised land. The dose was too low for visual or auditory hallucinations, which was perfectly fine with me. That night, sleep came late as my mind remained on high alert, vibrating with a new frequency, but there was no hangover, only the lingering memory of a beautiful, risk-taken peace.

This initial, gentle introduction was a stark contrast to later experiences. I had several extraordinary marathon acid trips of ten hours or more that exposed the unlimited creative and loving potential of the human mind, it is too bad I have no way to present the audio and video, and synesthesia that I experienced.

One time, I tried DMT, which was then called the “businessman’s LSD” because its effects lasted only a few hours compared to the all-day journey of an acid trip. Under its influence, I felt an incredible, almost telepathic kinship with every stranger I met. The usual barriers of fear and social anxiety dissolved, replaced by a sense of deep, unspoken understanding and connection. It was a chemical preview of the more natural, earned sense of unity that would come to me fifteen years later, after a long and arduous recovery from addiction.

Psychedelics, for me, were never about self-destruction. They were a delightful and eye-opening vacation from the dark certainties and crystallized structures of thought that characterized my troubled early life. They revealed a vast, creative beauty embodied within the unexplored regions of my consciousness. However, I lacked the spiritual and emotional maturity to integrate these profound experiences. My ego, while temporarily suspended, remained unexamined. It was a thrilling ride, but the real work was yet to begin.

I found that as I grew older, the experiences became less positive. In 1979, I used LSD for the last time. The trip was difficult, and it took two full days for me to feel normal again. During that second day, a terrifying fear gripped me: that I might be stuck forever in that anxious, in-between state, a short-circuited wire humming with panic. I was never tempted to use LSD again.

One of the most critical concepts in the responsible exploration of psychedelics is that of “set and setting.” First coined by Timothy Leary in the 1960s, these terms refer to the internal mindset (“set”) and the external physical and social environment (“setting”) in which the experience takes place. This isn’t a modern invention; ancient cultures understood this implicitly. The use of Ayahuasca in Amazonian tribal ceremonies, for example, is embedded in rituals, community, and the guidance of a shaman, creating a sacred container for the journey.

Modern research overwhelmingly supports this ancient wisdom. A favorable set and setting can significantly enhance the therapeutic benefits of psychedelics while minimizing the risks. This is not a reckless endeavor. Without a container of safety and support, the dissolution of the ego can be terrifying rather than transformative.

Mindset Preparation (Set): Before embarking on such a journey, it is crucial to engage in practices like meditation, journaling, and setting clear intentions. What are you seeking? Healing? Insight? Connection? A clear intention acts as a rudder in the vast ocean of consciousness.
Controlled Environment (Setting): The physical space should be safe, comfortable, and free from interruptions. The social setting is equally important; surrounding yourself with trusted, supportive individuals who understand and respect the process is paramount.

While the psychedelic experience itself can be transformative, the real work begins afterward. This is the process of integration—reflecting on the insights gained and weaving them into the fabric of daily life. Journaling, therapy with a trained professional, and sharing with a supportive community are all vital tools for ensuring that the journey leads to meaningful and lasting growth.

The Resistors: Alcohol and Cannabis

As we discuss the tools for accessing the universal bandwidth, we must also address the substances that often act as resistors, dampening the signal. The difference between expansion and escapism lies entirely in the intention of the user and the nature of the substance.

If psychedelics are the keys to the cosmos, alcohol is often the grease of the terrestrial realm. It is a fine social lubricant, capable of softening the rigid edges of social anxiety and allowing conversation to flow with greater ease. There is a certain camaraderie found in the sharing of wine or spirits, a ritual as old as civilization itself. However, conscious imbibing is a discipline that few master. Alcohol is seductive in its ability to numb, and therein lies its danger. While it may lower inhibitions, it also lowers our vibrational frequency if used without vigilance. The health issues that plague the habitual over-drinker are physical manifestations of a spiritual dampening. One must ask: Am I drinking to connect, or am I drinking to forget?

I drank to drunkenness every time I consumed alcohol from ages 15 through 30. I abstained from any alcohol use until 2006, when I started drinking beer again. I stopped drinking again in 2009, upon also quitting pain killer use. I drank alcohol again on a world cruise in 2023, consuming alcohol nearly every day on a 107-day around-the-world tour. I had a lot of great times with friends, and strangers, on our ocean voyage. Yet, upon rejoining my normal life, I no longer drank alcohol, other than an occasional drink with my wife Sharon. When I do drink alcohol, I mindfully embrace the whole experience, so that a historical, unconscious habitual response to alcohol does not take over. Alcohol is a dangerous drug, and our embrace of it and response to it needs to be done fully consciously and considerately.

Then there is cannabis, a plant revered by many cultures as a bridge to the divine. Many proclaim its ability to enhance spiritual connection and soften the harshness of reality. I do not deny this potential for others; however, the philosophical journey requires radical honesty about one’s own constitution. In my own exploration, I have found that cannabis does not liberate, but rather obscures. While it may offer relaxation, it extracts a heavy toll: the repression of my desire to create. The creative impulse is the deepest truth of the human experience, and for me, cannabis throws a heavy blanket over that flame. It hinders the sharing of my deepest truths with others, replacing active expression with passive observation.

Marijuana stunted my emotional and spiritual growth in the 1970s, when I smoked it nearly every day. I was an anxious and insecure teenager, and I would have been much better off had I stayed away from marijuana and dealt directly with the challenges of growing up. After total sobriety began in 1987, my mind quickly matured to the level it could have been, and should have been, years earlier.

For decades, I was satisfied with the spiritual connection I had cultivated through meditation, mindfulness, Twelve-Step work, and healthy living. But life has a way of presenting new challenges, new areas where the wiring has frayed. In October of 2022, after years of my wife Sharon and I studying the therapeutic applications of psychedelics, I attended a 14-hour spiritual retreat where an elixir made of five mushrooms, including psilocybin, was administered. It was the first psychedelic I had used since the 1970s and the most powerful and transcendent experience I had had in many years, including those manifested through meditation and nature walks.

To understand the value of this, we must look at how we typically process reality. We usually filter our existence through language. If I see a tree, my brain instantly labels it “tree,” and in that labeling, I cease to truly see the unique living entity before me. I see the concept, not the reality. Trauma and cultural conditioning operate the same way; they are linguistic and conceptual loops that tell us who we are before we have a chance to experience ourselves directly.

The true gift of the psychedelic experience is the occurrence of non-verbal insight. This is the capacity to see something directly, without the interference of the word or the concept. It is a form of “direct viewing” that bypasses the ego’s editorial department. When we access this state, we are not thinking about the universe; we are experiencing our continuity with it. This is transformative because it has the potential to change our neurobiological system.

Trauma often locks the brain into specific, rigid patterns of firing—high-alert loops that limit our consciousness to a bandwidth of survival and fear. The psychedelic experience, by dissolving these rigid networks (often referred to as the Default Mode Network), allows the brain to communicate in novel ways. It expands our consciousness away from the limitations wrought by trauma and cultural conditioning, allowing us to perceive the “is-ness” of things without the “ought-to-be” of our social programming. In this expanded state, the electrician is no longer just fixing a loose wire; he realizes he is part of the grid itself.

The Short Circuit: The Autoimmune Realization

During the retreat, Espree, the facilitator, after a period of deep meditation and extensive personal sharing, asked me a simple yet profound question: “Why do you not recognize yourself as a beautiful person?”

I replied from my conditioned mind. I told him that while I knew of my interior beauty and the beauty of my world, my body now showed the world anything but that. I am in my late 60s. I have psoriasis, skin cancer scars, and wrinkles on my neck that I often thought Botox would help. My body image acted as a static interference, keeping me from acknowledging the truth Espree wanted me to see—a truth my wife, Sharon, concurred with upon my return home.

I had long ago left that part of my biological and cultural self that sought a “perfect” body in a quest to be attractive to the opposite sex. My search had ended in that regard, as Sharon has been my life partner since 1989. Yet, I had forgotten to consciously cultivate my love for my body. I had trained it to a level of incredible fitness in previous years, yet trashed my leg bones with numerous stress fractures because of overuse. We crossed many mountains and finish lines together, often in a triumphant manner. Yet, I had failed to express gratitude for the continued miracle of its existence as the vehicle for my version of consciousness.

The facilitator stated that if I only perceived my beauty to be an interior phenomenon, I was still just living out of my “head space.” True beauty, she argued, is of THE WHOLE BEING—body, mind, and spirit. It is a reflection of our connection with Mother Earth and the Universe. We are all of immeasurable beauty and significance, and these two qualities must forever remain within our hearts, independent of our biological, social, and personal agendas, and—crucially—independent of the uninformed opinions of others.

If we do not claim this, our failure to conform to the expectations of others creates “internal informants.” These are the tricksters of the psyche. They fool us into accepting disfigured visions of ourselves, convincing us that the innate perfection of life has somehow skipped us.

Wow. That was quite a call on me.

It was in this moment that I saw it with stunning clarity: I have an autoimmune disease.

I am attacking myself.

This self-attack was manifesting physically, but its roots were in a false understanding of my body, a deep-seated self-negation born from early life trauma and reinforced by cultural conditioning. This self-negating fact was so normalized, so close to my own perception, that I had accepted it as a foundational subroutine of my identity. I was attacking myself through a false understanding of my body and its appearance to myself and to others. Should I have known better? Perhaps. But as I am an evolving consciousness, by remaining open to the wisdom of others, my own improving insight is enhanced and supported by other awakening souls and their compassionate feedback.

Mindfulness and meditation help keep us connected to the “what is,” and the light of that awareness can bring transformative changes to the “seer” and to our “seeing.” The psychedelic experience acted as a supercharger for this mindfulness, allowing me to see the mechanism of the attack in real-time. I saw the neural pathways of self-rejection lighting up, and for the first time, I had the choice not to travel down them. The psoriasis cleared up within six weeks, eliminating the need for $60,000-a-year biologic treatments like Skyrizi injections.

This struggle with the physical vessel is not unique to me. I was reminded of Marsha Feldman (deceased), a pulchritudinous friend of mine from the 1980s. Marsha had rejected me as a lover because I did not have the classic handsome characteristics that her heart had demanded of all her previous lovers. I was not emotionally impacted by her assessment, as I treasured her platonic friendship. Yet, I had to ask myself: Was the indifference that I exhibited only a façade? Was it an actual manifestation of some deeper denial, self-neglect, or even hatred?

Marsha had the most perfect body and face that I had ever seen. She was the picture of what society told us was the “ideal bandwidth” of human existence. Yet, even she was not happy. She suffered deeply. She even visited with her Rabbi several times, trying to get to the root of her unique problems. She, too, had an autoimmune disease and wanted her Rabbi to explain to her how she could find God and be healed of her suffering.

Her Rabbi told her, quite succinctly, that he had wasted much of his own life searching for God through scripture and laws, and he never found the Truth there. It was not until he began an intense exploration of himself that he finally arrived at the doorstep of the Truth. He advised Marsha to learn about herself—her judgments against others and against herself. He told her she must explore the darkest corners and secrets of her life: her relationship to her body, her friends, her enemies, her family, her loves, her hatreds, her employment, and her connection with Nature.

Marsha had to first see what “God” isn’t to find the path to what “God” is.

Her Rabbi stressed that if Marsha was to find the healing balm that God could provide, she had to first find herself. The Rabbi’s message is one for the ages and one for all of us. Marsha’s Rabbi recommended that even though she was not an alcoholic, she should try any twelve-step support group to begin exploration of her life at a deeper spiritual level. That is how I met her, at the 1987 International New Thought Alliance conference in Portland, at a talk given by the world-famous expert in twelve-step work, Jack Boland.

Jack Boland was a true master. Several years later, at another Portland speaking engagement, he had the temerity to tell me that I needed more pain in my life to motivate me to want to dive deeper into my true self and recovery. At the time, it felt harsh. Now, I see it as an electrical surge meant to blow a stuck fuse, forcing me to check the wiring.

Another great insight was gained through the retreat and feedback process, one that directly connects to the production of this very book. While in my spiritually adjusted state—a state of higher consciousness and wider bandwidth—I was able to see, without judgment, one of my last remaining attachments to ego identification, other than to my body.

It was my body of writing.

The same harsh judgment I heaped upon my body, I realized, I also directed at my body of writing. I had been trying to make my work more “presentable” to others, falling ill to the need to cater to external perceptions. The parallel was undeniable: my face and my writings both needed a “Botox treatment” to be acceptable. I saw how I had tried to sanitize my words, hoping to hide the evidence of our living, of our aging, of our suffering. But in doing so, we cut off the flow. We reduce the bandwidth. We present a plastic version of the universe rather than the electric, chaotic, beautiful truth of it.

In my most exalted state, I saw that my writings, just like my body, were suffering from an autoimmune disease—the disease where I permitted myself to attack myself for the failure of my self to make my appearance to others more pleasing.

This insight, delivered with the force of revelation under the influence of the medicine, was not just intellectual; it was experiential. I saw that my body and my writings are temporary containers for an infinite spiritual potential, created to serve as channels for its expression. The pain of my past, once an enemy, was now an unlikely teacher. This book is my way of rejecting gimmicky “creative botox” approaches to writing. This book has seventy chapters, and I did not hold back one iota in my “need” to protect the reader. It is up to the reader as to how far they might want to follow these verbal pathways.

The Science of Connection

This personal story mirrors a broader shift in the scientific and medical communities. Emerging research is validating what many have known for decades: psychedelics hold immense therapeutic potential. Clinical trials are demonstrating the efficacy of psilocybin, MDMA, and LSD in treating a range of mental health conditions, offering new hope where traditional treatments have failed.

Depression: Studies show that psilocybin-assisted therapy can lead to significant and sustained reductions in treatment-resistant depression.
PTSD: MDMA-assisted therapy is showing remarkable success in helping individuals process and heal from deep-seated trauma, even in chronic, treatment-resistant cases.
Anxiety and End-of-Life Care: For terminally ill patients, psychedelics have been shown to dramatically reduce or even eliminate the “death terrors” that so often accompany a terminal diagnosis, providing profound spiritual guidance and a sense of peace.

These are not miracle cures. Professional guidance in a controlled environment is essential. Psychedelics are not a one-size-fits-all solution; thorough medical and psychological assessments are necessary to tailor the approach to each individual. Bill Wilson, the co-founder of Alcoholics Anonymous, engaged in psychedelic therapy for his own chronic depression twenty years into his recovery, believing it could help those who struggled to find a connection to a Higher Power. Esteemed healers and thinkers like Deepak Chopra, Gabor Maté, and Dick Schwartz are now firm proponents of this form of healing.

The Lamp and The Path

My journey has taught me that these substances are neutral tools; they are keys. It is the hand that turns the key—and the intention behind it—that decides whether the door opens to a sanctuary or a prison. Mindful use demands brutal honesty about our motivations. Are we seeking to widen the bandwidth of our experience to let more joy in, or are we trying to drown out the noise of our own suffering?

If you feel called to this path, I urge you to proceed with the utmost care and respect. Research this subject as if for a graduate degree. Seek out trained facilitators and therapists who can provide a safe and supportive container for your journey. Beware of the consequences of bringing a highly chaotic mindset to this process; I recommend that you have already experienced a measure of healing, lest you find only more chaos.

Socrates warned that “the unexamined life is not worth living,” and I would add that examination requires not just intellect but an open heart—a willingness to see and feel what we have long buried. My own odyssey has convinced me that insight and mindfulness, met with self-compassion, form the lamp and the path.

If you are a spiritual seeker, a philosopher, an educator, a mental health professional, or someone in recovery, let this be your invitation. Healing begins in the honest, unvarnished acceptance of our full humanity—in the courageous sharing of our imperfect stories. It begins when we stop attacking ourselves for being human.

When we reclaim our experiences and write new, authentic narratives, we not only transform ourselves but also shine a light that beckons others toward their own wholeness. The universal bandwidth is vast, but it is only through lucid awareness that we can truly begin to hear its music. Let the word—truth, love, healing—dwell within us, lived and embodied. As we honor our own stories, frailties, and insights, we walk together toward the oneness and peace we all deserve, and—if we’re lucky—catch a glimpse of the miracle of simply being here, awake and alive, plugged into the infinite current of the universe.

Chapter 400: Psychedelics and the Human Mind: A Pathway to Healing and Insight

Mindset Preparation: Engage in practices like meditation, journaling, and setting clear intentions before your experience.
Controlled Environment: Choose a safe, comfortable space, preferably with someone you trust who can provide support.
Positive Social Setting: Surround yourself with supportive, like-minded individuals who understand and respect the process.

Practical Steps for Post-Experience Reflection and Growth

Journaling: Write down your thoughts and feelings about the experience.
Therapy Sessions: Work with a therapist who specializes in psychedelic integration.
Community Support: Join groups or forums where you can share your experiences and learn from others.

Essential Personalized Approaches

Medical Assessments: Consult healthcare providers to evaluate any potential contraindications.
Psychological Screenings: Ensure you’re in a stable mental state, free from untreated mental health conditions.
Informed Guidance: Seek advice from professionals experienced in psychedelic therapy.

Promising Research Areas

Depression: Studies indicate that psilocybin can help alleviate treatment-resistant depression.
Anxiety: MDMA-assisted therapy shows promise in reducing symptoms of anxiety, especially in patients with life-threatening illnesses.
PTSD: Early trials suggest that MDMA can significantly reduce PTSD symptoms, even in chronic, treatment-resistant cases.

Key Ethical Considerations

Informed Consent: Ensure participants fully understand the potential risks and benefits.
Accessibility: Advocate for equitable access to psychedelic therapies, regardless of socioeconomic status.
Regulation: Support policies that promote safe and controlled use while preventing misuse.

Proposed Future Directions

Policy Advocacy: Support legislation that allows for expanded research and controlled therapeutic use.
Rigorous Research: Fund and conduct studies to further understand the long-term effects and potential applications.
Educational Resources: Develop training programs for mental health professionals to safely incorporate psychedelics into their practice.

Chapter 2009: Timothy Leary and The Moody Blues

The relationship between The Moody Blues and psychologist Timothy Leary was a defining piece of late-1960s counterculture, highlighted by a famous musical tribute, a live stage appearance, and a later lyric revision.

The Song “Legend of a Mind”

The Tribute: Flautist and singer Ray Thomas wrote the psychedelic song “Legend of a Mind”, featuring the famous opening lines: “Timothy Leary’s dead / No, no, no, he’s outside looking in”.

The Intention: Thomas later shared that he wrote the track partly as a tongue-in-cheek nod after reading Leary’s work on eastern mysticism and the Tibetan Book of the Dead.

Leary’s Reaction: Leary expressed gratitude to Thomas, noting that the song actually made him far more famous than his academic and scientific work ever did.

Meeting and Live Performances

Stage Appearance: In November 1969, Timothy Leary joined The Moody Blues live on stage, sitting and playing a tambourine during their set at a free concert at Los Angeles’s Elysian Park.

Ongoing Contact: Keyboardist Mike Pinder also stayed in touch with Leary over the years, discussing his later ideas regarding space and technology.

Later Re-recording

Tribute Album: Following Leary’s death in May 1996, Mercury Records released the tribute album Beyond Life With Timothy Leary.

Lyric Change: The Moody Blues participated by re-recording “Legend of a Mind,” changing the famous opening line to “Timothy Leary lives”. Band member Justin Hayward later admitted mixed feelings about this commercial revision, feeling the original 1968 recording was best left untouched.

Timothy Leary’s dead
No, no, he’s outside looking in
Timothy Leary’s dead
No, no, he’s outside looking in
He’ll fly his astral plane
Takes you trips around the bay
Brings you back the same day
Timothy Leary, Timothy Leary

Along the coast you’ll hear them boast
About a light they say that shines so clear
So raise your glass, we’ll drink a toast
To the little man who sells you thrills along the pier

He’ll take you up, he’ll bring you down
He’ll plant your feet back firmly on the ground
He flies so high, he swoops so low
He knows exactly which way he’s gonna go

Section Eleven (special): Psychedelics (see chapters 36-38 in section eleven)

Published by Bruce Paullin on September 25, 2026September 25, 2026

Chapter 2001: The Doors of Perception — Psychedelics, the Sacred, and the Healing of a Wounded America

Chapter 2002: The Integration — From the Opened Door to the Inhabited Life

What Integration Actually Means

The Examined Life as Daily Practice

The 2022 Retreat: A Return to the Threshold

The Body of the Work: Practices for a Lived Awakening

The Convergence: Where the Medicine Meets the Path

A Final Word: The Wholeness That Was Always There

What Psychedelics Actually Are — And What They Do

The Entropic Brain: A New Framework for an Ancient Practice

The Ego and Its Discontents

The Personal Beginning: What the Body Knows Before the Mind Accepts

The Return: October 2022 and the Psilocybin Retreat

The Long Tradition: Psychedelics Through the Ages

The Healing of Meaning: What Depression Actually Is

The American Context: Healing in an Age of Emptiness

Chapter 2026: The Doors of Perception — Psychedelics, the Sacred, and the Healing of a Wounded America

apter 2000: LSD and Others.

Mapping Local Brain Disruptions

Shifting the Balance of Excitement and Inhibition

Altering Emotional Responses with Low Doses

Tracking Mood Elevations Through Microdosing

Exploring Population-Level Behavioral Links

Uncovering Unexpected Neuroprotective Properties

Engineering a Hallucination-Free Alternative

Limitations and Future Directions

Chapter 1000: Nature Communications

Chapter 800: Ayahuasca, Mushrooms, LSD: Businessman’s Spirituality?

Chapter 700: Psychedelic Assisted Recovery From Trauma And Alcoholism

Chapter 600: The Healing Potential of Psilocybin Cubensis

Chapter 500: Navigating an Unassisted Psychedelic Journey for Health and Wellness

Chapter 21 – Recovery, Healing, and Psychedelics

Chapter 48: A Connection to the Infinite? – Psychedelics and Self-Discovery

Like this:

Bruce Paullin

Section Eleven: Psychedelics and Healing

Section Nine: Dreams and Inner Vision

Section Nine: Dreams and Other Visions

Section Eleven (special): Psychedelics (see chapters 36-38 in section eleven)

Published by Bruce Paullin on September 25, 2026September 25, 2026

Chapter 2001: The Doors of Perception — Psychedelics, the Sacred, and the Healing of a Wounded America

Chapter 2002: The Integration — From the Opened Door to the Inhabited Life

What Integration Actually Means

The Examined Life as Daily Practice

The 2022 Retreat: A Return to the Threshold

The Body of the Work: Practices for a Lived Awakening

The Convergence: Where the Medicine Meets the Path

A Final Word: The Wholeness That Was Always There

What Psychedelics Actually Are — And What They Do

The Entropic Brain: A New Framework for an Ancient Practice

The Ego and Its Discontents

The Personal Beginning: What the Body Knows Before the Mind Accepts

The Return: October 2022 and the Psilocybin Retreat

The Long Tradition: Psychedelics Through the Ages

The Healing of Meaning: What Depression Actually Is

The American Context: Healing in an Age of Emptiness

Chapter 2026: The Doors of Perception — Psychedelics, the Sacred, and the Healing of a Wounded America

apter 2000: LSD and Others.

Mapping Local Brain Disruptions

Shifting the Balance of Excitement and Inhibition

Altering Emotional Responses with Low Doses

Tracking Mood Elevations Through Microdosing

Exploring Population-Level Behavioral Links

Uncovering Unexpected Neuroprotective Properties

Engineering a Hallucination-Free Alternative

Limitations and Future Directions

Chapter 1000: Nature Communications

Chapter 800: Ayahuasca, Mushrooms, LSD: Businessman’s Spirituality?

Chapter 700: Psychedelic Assisted Recovery From Trauma And Alcoholism

Chapter 600: The Healing Potential of Psilocybin Cubensis

Chapter 500: Navigating an Unassisted Psychedelic Journey for Health and Wellness

Chapter 21 – Recovery, Healing, and Psychedelics

Chapter 48: A Connection to the Infinite? – Psychedelics and Self-Discovery

Share this:

Like this:

Bruce Paullin

Related Posts

Section Eleven: Psychedelics and Healing

Section Nine: Dreams and Inner Vision

Section Nine: Dreams and Other Visions